FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Rutgeerts

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Phenomena

Recurrence

Procedures

Physiology

Genetic Predisposition to Disease

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Anthony de Buck van Overstraeten; Freddy Penninckx; Paul Rutgeerts; Gert van Assche; Séverine Vermeire; Albert M Wolthuis; André D'Hoore
Intersphincteric proctectomy with end-colostomy for anorectal Crohn's disease results in early and severe proximal colonic recurrence.
N Vande Casteele; S Vermeire; Paul Rutgeerts; S Brecx; P Declerck; M Ferrante; A Gils
Letter: dry blood spots for anti-TNF treatment monitoring in IBD.
Bart Lemmens; Paul Rutgeerts; Xavier Sagaert; Gert Van Assche; Séverine Vermeire; Ingrid Arijs; Marc Ferrante; Karel Geboes; Gert De Hertogh
Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Rutgeerts (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anthony de Buck van Overstraeten; Freddy Penninckx; Paul Rutgeerts; Gert van Assche; Séverine Vermeire; Albert M Wolthuis; André D'Hoore
Intersphincteric proctectomy with end-colostomy for anorectal Crohn's disease results in early and severe proximal colonic recurrence.
Journal of Crohn's & colitis 2013;7(6):e227-31.
2013: N Vande Casteele; S Vermeire; Paul Rutgeerts; S Brecx; P Declerck; M Ferrante; A Gils
Letter: dry blood spots for anti-TNF treatment monitoring in IBD.
Alimentary pharmacology & therapeutics 2013;37(10):1024-5.
2013: Bart Lemmens; Paul Rutgeerts; Xavier Sagaert; Gert Van Assche; Séverine Vermeire; Ingrid Arijs; Marc Ferrante; Karel Geboes; Gert De Hertogh
Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis.
Inflammatory bowel diseases 2013;19(6):1194-201.
2013: Marc Ferrante; Séverine Vermeire; Paul Rutgeerts
Certolizumab pegol in the treatment of Crohn's disease.
Expert opinion on biological therapy 2013;13(4):595-605.
2013: Ingrid Arijs; Paul Rutgeerts; Frans Schuit; Wiebe Vanhove; Kristin Verbeke; Vicky De Preter
Decreased mucosal sulfide detoxification capacity in patients with Crohn's disease.
Inflammatory bowel diseases 2013;19(5):E70-2.
2013: Vicky De Preter; Paul Rutgeerts; Frans Schuit; Kristin Verbeke; Ingrid Arijs
Impaired expression of genes involved in the butyrate oxidation pathway in Crohn's disease patients.
Inflammatory bowel diseases 2013;19(3):E43-4.
2013: Séverine Vermeire; Paul Rutgeerts
IBD in 2012: Pathogenesis and management of IBD--thinking outside the box.
Nature reviews. Gastroenterology & hepatology 2013;10(2):67-9.
2013: Clémentine Perrier; Paul Rutgeerts; David E Szymkowski; Gert Van Assche; Severine Vermeire; Jonathan Cremer; Gert de Hertogh; Jan L Ceuppens
Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis.
Inflammatory bowel diseases 2013;19(2):246-53.
2013: Vicky De Preter; Marie Joossens; Paul Rutgeerts; Ziv Shkedy; Vera Ballet; Severine Vermeire; Kristin Verbeke Phd
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial.
Clinical and translational gastroenterology 2013;4():e30.
2013: Clémentine Perrier; Paul Rutgeerts; Frans Schuit; Dominiek Staelens; Gert van Assche; Séverine Vermeire; Isabelle Cleynen; Kris Covens; Gert De Hertogh; Marc Ferrante; Ingrid Arijs; Christine Breynaert; Jan L Ceuppens
Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.
Immunology 2013;138(1):47-56.
2012: Laurent Peyrin-Biroulet; Walter Reinisch; Paul Rutgeerts; Stefan Schreiber; Flávio Steinwurz; Simon Travis; Laurent Beaugerie; Vincent Billioud; Yehuda Chowers; Jean-Frédéric Colombel; Silvio Danese; Geert D'Haens; Brian Feagan; Toshifumi Hibi; Peter Higgins; Edouard Louis; Haruhiko Ogata; Remo Panaccione; Julian Panés; William J Sandborn
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
The American journal of gastroenterology 2012;107(12):1770-6.
2012: Geert D'Haens; Brian Feagan; Richard N Fedorak; Steven Hanauer; Marc Lémann; Jean-Yves Mary; Walter Reinisch; Paul Rutgeerts; William J Sandborn; Frank Carbonnel; Jean-Frédéric Colombel; Silvio Danese
Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.
Gastroenterology 2012;143(6):1461-9.
2012: Vicky De Preter; Paul Rutgeerts; Frans Schuit; Wiebe Vanhove; Severine Vermeire; Karen Windey; Ingrid Arijs; Kristin Verbeke
Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis.
Inflammatory bowel diseases 2012;18(12):2371-80.
2012: Geert D'Haens; Marc Ferrante; Patricia Geens; Doreen Iwens; Liesbeth Moortgat; Maja Noman; Isolde Aerden; Filip Baert; Gert van Assche; Gust Van Olmen; Severine Vermeire; Paul Rutgeerts
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
Inflammatory bowel diseases 2012;18(12):2218-24.
2012: Talat Bessissow; Raf Bisschops; Marc Ferrante; Karel Geboes; Bart Lemmens; Paul Rutgeerts; Gert van Assche; Kristel Van Steen; Séverine Vermeire; Gert De Hertogh
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.
The American journal of gastroenterology 2012;107(11):1684-92.
2012: T Bessissow; I Hoffman; M Renard; Paul Rutgeerts; S Vermeire; G Van Assche
Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy.
Alimentary pharmacology & therapeutics 2012;36(4):312-23.
2012: Gary Toedter; Gary D Wu; Ingrid Arijs; Renée Deehan; James D Lewis; Katherine Li; Keying Ma; Michael Macoritto; Colleen Marano; Andrea Matthews; Jennifer Park; Paul Rutgeerts; Sarah Sague; Frédéric Baribaud
Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy.
Inflammatory bowel diseases 2012;18(8):1399-410.
2012: Severine Vermeire; Gert van Assche; Paul Rutgeerts
Classification of inflammatory bowel disease: the old and the new.
Current opinion in gastroenterology 2012;28(4):321-6.
2012: Gary R Lichtenstein; Jennifer Montello; Paul Rutgeerts; William J Sandborn; Bruce E Sands; Linda Tang; Marion Blank; Freddy Cornillie; Robert H Diamond; Jean-Frédéric Colombel
A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease.
The American journal of gastroenterology 2012;107(7):1051-63.
2012: William J Sandborn; Bruce E Sands; Stefan Schreiber; Stephan R Targan; Richard Aranda; Brian Bressler; Jean-Frederic Colombel; Karl Geboes; Sheila Gujrathi; Allison Luo; Remo Panaccione; Yun Peng; Paul Rutgeerts; Luisa Salter-Cid; Stephen B Hanauer
Abatacept for Crohn's disease and ulcerative colitis.
Gastroenterology 2012;143(1):62-69.e4.
2012: Ingrid Arijs; Gert De Hertogh; Bart Lemmens; Frans Schuit; Jan Van der Goten; Séverine Vermeire; Paul Rutgeerts
Intestinal expression of SHIP in inflammatory bowel diseases.
Gut 2012;61(6):956-7.
2012: Vicky De Preter; Paul Rutgeerts; Frans Schuit; Wiebe Vanhove; Severine Vermeire; Karen Windey; Ingrid Arijs; Kristin Verbeke
Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway.
Inflammatory bowel diseases 2012;18(6):1127-36.
2012: Marie Joossens; Paul Rutgeerts; Kristin Verbeke; Vera Ballet; Vicky De Preter; Severine Vermeire
Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial.
Gut 2012;61(6):958.
2012: Paul Rutgeerts; William J Sandborn; Gert van Assche; Douglas C Wolf; Karel Geboes; Ashish Kumar; Andreas Lazar; Kathleen G Lomax; Paul F Pollack; Walter Reinisch; Anne Camez; Jean-Frédéric Colombel; Geert D'Haens
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.
Gastroenterology 2012;142(5):1102-1111.e2.
2012: Gert van Assche; L Van der Biest; Severine Vermeire; A Wolthuis; Marc Ferrante; M Noman; Freddy Penninckx; K Rans; Paul Rutgeerts; Andre D'Hoore
Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2012;14(4):e181-6.
2012: L Márquez; S Organe; C Perrier; Paul Rutgeerts; C Shen; Kristel van Steen; V Ballet; Jan L Ceuppens; I Cleynen; Gert De Hertogh; Marc Ferrante; G Galicia; Liesbet Henckaerts; K Machiels; Severine Vermeire
Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.
Gut 2012;61(4):528-34.
2012: Anne Christine W Vos; Manon E Wildenberg; Ingrid Arijs; Gert De Hertogh; Marjolijn Duijvestein; Paul Rutgeerts; Gijs R van den Brink; Auke Verhaar; Séverine Vermeire; Daan W Hommes
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.
Inflammatory bowel diseases 2012;18(3):401-8.
2012: Simon Travis; Brian G Feagan; Paul Rutgeerts; Sander van Deventer
The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.
Journal of Crohn's & colitis 2012;6 Suppl 2():S250-9.
2012: Marko Brinar; Isabelle Cleynen; Karel Geboes; Liesbet Henckaerts; Bart Lemmens; Paul Rutgeerts; Xavier Sagaert; Gert van Assche; Séverine Vermeire; Gert De Hertogh
Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients.
Journal of Crohn's & colitis 2012;6(1):43-50.
2012: Clémentine Perrier; Paul Rutgeerts
New drug therapies on the horizon for IBD.
Digestive diseases (Basel, Switzerland) 2012;30 Suppl 1():100-5.
2012: Paul Rutgeerts
How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?
Digestive diseases (Basel, Switzerland) 2012;30(4):396-9.
2012: Maureen J Koslowski; Irmgard Kübler; Walter Reinisch; Paul Rutgeerts; Elke Schaeffeler; Matthias Schwab; Eduard F Stange; Zora Teltschik; Séverine Vermeire; Guoxing Wang; Julia Beisner; Rachel Cooney; Michael Gersemann; Derek Jewell; Jan Wehkamp
Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.
PLoS genetics 2012;8(2):e1002523.
2012: Katrijn Op De Beéck; Paul Rutgeerts; Séverine Vermeire; Xavier Bossuyt
Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases.
Gut 2012;61(1):162-4; author reply 164-5.
2011: Clémentine Perrier; Paul Rutgeerts
Cytokine blockade in inflammatory bowel diseases.
Immunotherapy 2011;3(11):1341-52.
2011: Katrijn Op De Beéck; Paul Rutgeerts; Karolien Van den Bergh; Séverine Vermeire; Etienne Waelkens; Sofie Decock; Rita Derua; Frederik Nevens; Xavier Bossuyt
Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders.
Gut 2011;60(11):1601-2.
2011: Jean-Frédéric Colombel; Dirk Esser; Brian G Feagan; Stephen B Hanauer; Yinghua Lang; Gary R Lichtenstein; Colleen W Marano; Björn J Oddens; Daniel Present; Walter Reinisch; Paul Rutgeerts; Bruce E Sands; Richard Strauss; Yanxin Wang; William J Sandborn
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Gastroenterology 2011;141(4):1194-201.
2011: Fabian Schnitzler; Bernard Spitz; Gert van Assche; Kristel van Steen; Séverine Vermeire; Vera Ballet; Marc Ferrante; Herma Fidder; Ilse Hoffman; Maja Noman; Paul Rutgeerts
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.
Inflammatory bowel diseases 2011;17(9):1846-54.
2011: N Vande Casteele; S Vermeire; C Breynaert; A Gils; Paul Rutgeerts; G Van Assche
Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay.
Alimentary pharmacology & therapeutics 2011;34(3):401-3; author reply 404-5.
2011: William J Sandborn; Stefan Schreiber; Ziad H Younes; Ralph Bloomfield; Geoffroy Coteur; Brian G Feagan; Juan Pablo Guzman; Paul Rutgeerts; Geert R D'Haens
Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(8):670-678.e3.
2011: Gary Toedter; C Chris Huang; Katherine Li; Keying Ma; Colleen Marano; Paul Rutgeerts; Sarah Sague; Xiao-Yu Song; Frédéric Baribaud
Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis.
The American journal of gastroenterology 2011;106(7):1272-80.
2011: Liesbet Henckaerts; Isabelle Cleynen; Marko Brinar; Jestinah Mahachie John; Kristel van Steen; Paul Rutgeerts; Séverine Vermeire
Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease.
Inflammatory bowel diseases 2011;17(6):1392-7.
2011: Nathalie Vermeulen; Katrijn Op de Béeck; Severine Vermeire; Georges Michiels; Vera Ballet; Paul Rutgeerts; Kristel Van Steen; Xavier Bossuyt
Identification of a novel autoantigen in inflammatory bowel disease by protein microarray.
Inflammatory bowel diseases 2011;17(6):1291-300.
2011: Vicky De Preter; Aklilu Habteab Ghebretinsae; José Cortinas Abrahantes; Karen Windey; Paul Rutgeerts; Kristin Verbeke
Impact of the synbiotic combination of Lactobacillus casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in healthy subjects.
Molecular nutrition & food research 2011;55(5):714-22.
2011: Marie Joossens; Geert Huys; Margo Cnockaert; Vicky De Preter; Kristin Verbeke; Paul Rutgeerts; Peter Vandamme; Severine Vermeire
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.
Gut 2011;60(5):631-7.
2011: Christine Breynaert; Marc Ferrante; Herma Fidder; Kristel van Steen; Maja Noman; Vera Ballet; Séverine Vermeire; Paul Rutgeerts; Gert van Assche
Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study.
The American journal of gastroenterology 2011;106(4):778-85.
2011: Ingrid Arijs; Gert De Hertogh; Kathleen Machiels; Kristel van Steen; Katleen Lemaire; Anica Schraenen; Leentje Van Lommel; Roel Quintens; Gert van Assche; Séverine Vermeire; Frans Schuit; Paul Rutgeerts
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment.
The American journal of gastroenterology 2011;106(4):748-61.
2011: Brian G Feagan; William J Sandborn; D C Wolf; Geoffroy Coteur; O Purcaru; Y Brabant; Paul Rutgeerts
Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximab.
Alimentary pharmacology & therapeutics 2011;33(5):541-50.
2011: Marie Joossens; Geert Huys; Kristel van Steen; Margo Cnockaert; Séverine Vermeire; Paul Rutgeerts; Kristin Verbeke; Peter Vandamme; Vicky De Preter
High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake.
FEMS microbiology ecology 2011;75(2):343-9.
2011: Konstantinos Karmiris; Didier Bielen; Dirk Vanbeckevoort; Severine Vermeire; Georges Coremans; Paul Rutgeerts; Gert van Assche
Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(2):130-6.
2011: Nathalie Vermeulen; Severine Vermeire; Ingrid Arijs; Georges Michiels; Vera Ballet; Rita Derua; Etienne Waelkens; Leentje Van Lommel; Frans Schuit; Paul Rutgeerts; Xavier Bossuyt
Seroreactivity against glycolytic enzymes in inflammatory bowel disease.
Inflammatory bowel diseases 2011;17(2):557-64.
2011: Isabelle Cleynen; Peter Jüni; Eliane Kellen; Camila T Mendes; Eveline Nüesch; Paul Rutgeerts; Stefanie Schmied; Séverine Vermeire; Peter M Villiger; Stefan Wyder; Geertruida E Bekkering; Daniel Lottaz
Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review.
PloS one 2011;6(9):e24106.
2011: A M Wolthuis; Paul Rutgeerts; F Penninckx; A D'Hoore
A novel hybrid technique using transanal endoscopic microsurgery and balloon dilation in the treatment of a benign complete colorectal anastomotic stricture.
Endoscopy 2011;43 Suppl 2 UCTN():E176-7.
2011: Yukihide Momozawa; Myriam Mni; Kayo Nakamura; Wouter Coppieters; Sven Almer; Leila Amininejad; Isabelle Cleynen; Jean-Frédéric Colombel; Peter de Rijk; olivier dewit; Yigael Finkel; Miquel A Gassull; Dirk Goossens; Debby Laukens; Marc Lémann; Cecile Libioulle; Colm O'Morain; Catherine Reenaers; Paul Rutgeerts; Curt Tysk; Diana Zelenika; Mark Lathrop; Jurgen Del-Favero; Jean-Pierre Hugot; Martine De Vos; Denis Franchimont; Severine Vermeire; Edouard Louis; Michel Georges
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease.
Nature genetics 2011;43(1):43-7.
2011: Séverine Vermeire; Gert van Assche; Paul Rutgeerts
Inflammatory bowel disease and colitis: new concepts from the bench and the clinic.
Current opinion in gastroenterology 2011;27(1):32-7.
2011: Gert van Assche; Séverine Vermeire; Paul Rutgeerts
Management of acute severe ulcerative colitis.
Gut 2011;60(1):130-3.
2010: Valérie Van Hauwaert; Stef Meers; Gregor Verhoef; Thomas Tousseyn; Xavier Sagaert; Séverine Vermeire; Paul Rutgeerts; Gert Van Assche
Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis.
Journal of Crohn's & colitis 2010;4(6):683-6.
2010: Ingrid Arijs; Roel Quintens; Leentje Van Lommel; Kristel van Steen; Gert De Hertogh; Katleen Lemaire; Anica Schraenen; Clémentine Perrier; Gert van Assche; Séverine Vermeire; Karel Geboes; Frans Schuit; Paul Rutgeerts
Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease.
Inflammatory bowel diseases 2010;16(12):2090-8.
2010: Marko Brinar; Isabelle Cleynen; Tamara Coopmans; Gert van Assche; Paul Rutgeerts; Severine Vermeire
Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity.
Gut 2010;59(12):1728-9; author reply 1729-30.
2010: I J J Claes; Sarah Lebeer; Chong Shen; Tine L A Verhoeven; E Dilissen; Gert De Hertogh; dominique ma bullens; Jan L Ceuppens; Gert van Assche; Severine Vermeire; Paul Rutgeerts; Jos Vanderleyden; Sigrid C J De Keersmaecker
Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.
Clinical and experimental immunology 2010;162(2):306-14.
2010: C Janneke van der Woude; Pieter C F Stokkers; Ad van Bodegraven; Gert Van Assche; Zbigniew Hebzda; Leszek Paradowski; Geert D'Haens; Subrata Ghosh; Brian Feagan; Paul Rutgeerts; Gerard Dijkstra; Dirk J de Jong; Bas Oldenburg; Mahdi Farhan; Tristan Richard; Yann Dean; Daniel W Hommes
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease.
Inflammatory bowel diseases 2010;16(10):1708-16.
2010: Gert van Assche; Séverine Vermeire; Maja Noman; Christine Amant; Ellen Weyts; Anita Vleminckx; Marie-Josée Vermeyen; Paul Rutgeerts
Infliximab administered with shortened infusion times in a specialized IBD infusion unit: a prospective cohort study.
Journal of Crohn's & colitis 2010;4(3):329-33.
2010: William J Sandborn; Maria Abreu; Geert D'Haens; Jean-Frédéric Colombel; Severine Vermeire; Krassimir Mitchev; Corinne Jamoul; Richard N Fedorak; Martina E Spehlmann; Douglas C Wolf; Scott Lee; Paul Rutgeerts
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(8):688-695.e2.
2010: Zhe Li; Ingrid Arijs; Gert De Hertogh; Severine Vermeire; Maja Noman; dominique ma bullens; Lieve Coorevits; Xavier Sagaert; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens; Gert van Assche
Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.
Inflammatory bowel diseases 2010;16(8):1299-310.
2010: Peter Suenaert; Philippe Maerten; Gert van Assche; Willy Van Driessche; Karel Geboes; Veerle Bulteel; Jeannine Simaels; Patrick Augustijns; Jan L Ceuppens; Paul Rutgeerts; Clémentine Perrier
Effects of T cell-induced colonic inflammation on epithelial barrier function.
Inflammatory bowel diseases 2010;16(8):1322-31.
2010: Severine Vermeire; Gert van Assche; Paul Rutgeerts
Role of genetics in prediction of disease course and response to therapy.
World journal of gastroenterology : WJG 2010;16(21):2609-15.
2010: Iris Dotan; Daniel Rachmilewitz; Stefan Schreiber; Rami Eliakim; C Janneke van der Woude; Asher Kornbluth; Alan L Buchman; Shimon Bar-Meir; Bernd Bokemeyer; Eran Goldin; Christian Maaser; Uma Mahadevan; Ursula Seidler; Jörg C Hoffman; Douglas Homoky; Terry Plasse; Barbara Powers; Paul Rutgeerts; Daniel Hommes
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Gut 2010;59(6):760-6.
2010: Remo Panaccione; J-F Colombel; William J Sandborn; Paul Rutgeerts; G R D'Haens; A M Robinson; J Chao; P M Mulani; P F Pollack
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease.
Alimentary pharmacology & therapeutics 2010;31(12):1296-309.
2010: Liesbet Henckaerts; Robert Francois Vlietinck; Catherine Derom; Steven Boonen; Paul Rutgeerts; Severine Vermeire
Transmission ratio distortion of DLG5 R30Q: evidence for prenatal selection?
Inflammatory bowel diseases 2010;16(6):910-1.
2010: Jean-Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Infliximab, azathioprine, or combination therapy for Crohn's disease.
The New England journal of medicine 2010;362(15):1383-95.
2010: Andre Franke; Tobias Balschun; Christian Sina; David Ellinghaus; Robert Häsler; Gabriele Mayr; Mario Albrecht; Michael Wittig; Eva Buchert; Susanna Nikolaus; Christian Gieger; H-Erich Wichmann; Jurgita Sventoraityte; Limas Kupcinskas; Clive M Onnie; Maria Gazouli; Nicholas P Anagnou; David Strachan; Wendy L McArdle; Christopher G Mathew; Paul Rutgeerts; Séverine Vermeire; Morten H Vatn; Michael Krawczak; Philip Rosenstiel; Tom H Karlsen; Stefan Schreiber
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).
Nature genetics 2010;42(4):292-4.
2010: Séverine Vermeire; Gert Van Assche; Paul Rutgeerts
Postinfectious irritable bowel syndrome: a genetic link identified?
Gastroenterology 2010;138(4):1246-9.
2010: Severine Vermeire; Stefan Schreiber; William J Sandborn; Cécile Dubois; Paul Rutgeerts
Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(4):357-63.
2010: Martin H Holtmann; Frank Krummenauer; Christina Claas; Kristina Kremeyer; Dirk Lorenz; Olivia Rainer; Iris Vogel; Ulrich Böcker; Stephan Böhm; Carsten Büning; Rainer Duchmann; Guido Gerken; Hans Herfarth; Norbert Lügering; Wolfgang Kruis; Max Reinshagen; Jan Schmidt; Andreas Stallmach; Jürgen Stein; Andreas Sturm; Peter R Galle; Daan W Hommes; Geert D'Haens; Paul Rutgeerts; Markus F Neurath
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
Digestive diseases and sciences 2010;55(4):1066-78.
2010: Lieselotte Cloetens; Willem F Broekaert; Yasmine Delaedt; Frans Ollevier; Christophe M Courtin; Jan A Delcour; Paul Rutgeerts; Kristin Verbeke
Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study.
The British journal of nutrition 2010;103(5):703-13.
2010: C Thienpont; A D'Hoore; Severine Vermeire; I Demedts; Raf Bisschops; Georges Coremans; Paul Rutgeerts; Gert van Assche
Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy.
Gut 2010;59(3):320-4.
2010: Gert van Assche; Séverine Vermeire; Paul Rutgeerts
Mucosal healing and anti TNFs in IBD.
Current drug targets 2010;11(2):227-33.
2010: Gert van Assche; Séverine Vermeire; Paul Rutgeerts
The potential for disease modification in Crohn's disease.
Nature reviews. Gastroenterology & hepatology 2010;7(2):79-85.
2010: Filip Van Immerseel; Richard Ducatelle; Martine De Vos; Nico Boon; Tom Van De Wiele; kristin verbeke; Paul Rutgeerts; Benedikt Sas; Petra Louis; Harry J Flint
Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease.
Journal of medical microbiology 2010;59(Pt 2):141-3.
2010: Filip Baert; Liesbeth Moortgat; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Martine De Vos; Pieter Stokkers; Daniel Hommes; Paul Rutgeerts; Severine Vermeire; Geert D'Haens
Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Gastroenterology 2010;138(2):463-8; quiz e10-1.
2010: Gary R Lichtenstein; Paul Rutgeerts
Importance of mucosal healing in ulcerative colitis.
Inflammatory bowel diseases 2010;16(2):338-46.
2010: Marc Ferrante; Geert D'Haens; olivier dewit; Filip Baert; Jan Holvoet; Karel Geboes; Gert De Hertogh; Gert van Assche; Severine Vermeire; Paul Rutgeerts
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.
Inflammatory bowel diseases 2010;16(2):243-9.
2010: Walter Reinisch; Williem de Villiers; László Bene; László Simon; István Rácz; Seymour Katz; István Altorjay; Brian Feagan; Dennis Riff; Charles N Bernstein; Daniel Hommes; Paul Rutgeerts; Antoine Cortot; Michael Gaspari; May Cheng; Tillman Pearce; Bruce E Sands
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study.
Inflammatory bowel diseases 2010;16(2):233-42.
2010: Els Houben; Henrike M Hamer; Anja Luypaerts; Vicky De Preter; Pieter Evenepoel; Paul Rutgeerts; Kristin Verbeke
Quantification of (15)N-nitrate in urine with gas chromatography combustion isotope ratio mass spectrometry to estimate endogenous NO production.
Analytical chemistry 2010;82(2):601-7.
2010: Severine Vermeire; Gert van Assche; Paul Rutgeerts
Vaccination and infection prevention in inflammatory bowel disease.
F1000 medicine reports 2010;2():80.
2010: Isabelle Cleynen; Jestinah M Mahachie John; Liesbet Henckaerts; Wouter Van Moerkercke; Paul Rutgeerts; Kristel van Steen; Severine Vermeire
Molecular reclassification of Crohn's disease by cluster analysis of genetic variants.
PloS one 2010;5(9):e12952.
2010: Paul Rutgeerts; Severine Vermeire; Gert van Assche
Predicting the response to infliximab from trough serum levels.
Gut 2010;59(1):7-8.
2010: Marie Joossens; Kristel van Steen; Julien Branche; Boualem Sendid; Paul Rutgeerts; Francis Vasseur; Daniel Poulain; Franck Broly; Jean-Frédéric Colombel; Severine Vermeire; Mathias Chamaillard
Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease.
Inflammatory bowel diseases 2010;16(1):58-67.
2009: Marc Ferrante; Geert D'Haens; Paul Rutgeerts; Séverine Vermeire; Gert van Assche
Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Current gastroenterology reports 2009;11(6):504-8.
2009: I Arijs; K Li; G Toedter; R Quintens; L Van Lommel; Kristel van Steen; P Leemans; Gert De Hertogh; K Lemaire; Marc Ferrante; F Schnitzler; Lieven Thorrez; K Ma; X-Y R Song; C Marano; Gert van Assche; Severine Vermeire; Karel Geboes; F Schuit; F Baribaud; Paul Rutgeerts
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
Gut 2009;58(12):1612-9.
2009: Geert D'Haens; Paul Rutgeerts
Immunosuppression-associated lymphoma in IBD.
Lancet 2009;374(9701):1572-3.
2009: Konstantinos Karmiris; Gilles Paintaud; Maja Noman; Charlotte Magdelaine-Beuzelin; Marc Ferrante; Danielle Degenne; Kathleen Claes; Tamara Coopman; Nele Van Schuerbeek; Gert van Assche; Severine Vermeire; Paul Rutgeerts
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.
Gastroenterology 2009;137(5):1628-40.
2009: C Ruffolo; Freddy Penninckx; G Van Assche; Severine Vermeire; Paul Rutgeerts; Georges Coremans; Andre D'Hoore
Outcome of surgery for rectovaginal fistula due to Crohn's disease.
The British journal of surgery 2009;96(10):1190-5.
2009: William J Sandborn; Paul Rutgeerts; Brian G Feagan; Walter Reinisch; Allan Olson; Jewel Johanns; Jiandong Lu; Kevin Horgan; Daniel Rachmilewitz; Stephen B Hanauer; Gary R Lichtenstein; Willem J S de Villiers; Daniel H Present; Bruce Sands; Jean-Frédéric Colombel
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Gastroenterology 2009;137(4):1250-60; quiz 1520.
2009: Liesbet Henckaerts; Kristel van Steen; Isabel Verstreken; Isabelle Cleynen; Andre Franke; Stefan Schreiber; Paul Rutgeerts; Severine Vermeire
Genetic risk profiling and prediction of disease course in Crohn's disease patients.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(9):972-980.e2.
2009: Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert van Assche; Ilse Hoffman; Kristel van Steen; Severine Vermeire; Paul Rutgeerts
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.
Inflammatory bowel diseases 2009;15(9):1295-301.
2009: Annie Standaert-Vitse; Boualem Sendid; Marie Joossens; Nadine François; Peggy Vandewalle-El Khoury; Julien Branche; Herbert Van Kruiningen; Thierry Jouault; Paul Rutgeerts; Corinne Gower-Rousseau; Christian Libersa; Christel Neut; Franck Broly; Mathias Chamaillard; Séverine Vermeire; Daniel Poulain; Jean-Frédéric Colombel
Candida albicans colonization and ASCA in familial Crohn's disease.
The American journal of gastroenterology 2009;104(7):1745-53.
2009: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Immunosuppression in inflammatory bowel disease: traditional, biological or both?
Current opinion in gastroenterology 2009;25(4):323-8.
2009: Jean-Frédéric Colombel; D A Schwartz; William J Sandborn; M A Kamm; Geert D'Haens; Paul Rutgeerts; Robert Enns; Remo Panaccione; Stefan Schreiber; J Li; J D Kent; K G Lomax; Paul F Pollack
Adalimumab for the treatment of fistulas in patients with Crohn's disease.
Gut 2009;58(7):940-8.
2009: Marc Ferrante; Andre D'Hoore; Severine Vermeire; S Declerck; Maja Noman; Gert van Assche; Ilse Hoffman; Paul Rutgeerts; Freddy Penninckx
Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis.
Inflammatory bowel diseases 2009;15(7):1062-70.
2009: Maria Abreu; Christian von Tirpitz; Robert Hardi; Martin Kaatz; Gert Van Assche; Paul Rutgeerts; Emil Bisaccia; Sergi Goerdt; Stephen Hanauer; Robert Knobler; Peter Mannon; Lloyd Mayer; Thomas Ochsenkuhn; William J Sandborn; Dennis Parenti; Kevin Lee; Walter Reinisch
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
Inflammatory bowel diseases 2009;15(6):829-36.
2009: Jean-Frédéric Colombel; William J Sandborn; Paul Rutgeerts; Michael A Kamm; Andrew P Yu; Eric Q Wu; Paul F Pollack; Kathleen G Lomax; Jingdong Chao; Parvez Mulani
Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
The American journal of gastroenterology 2009;104(5):1170-9.
2009: Charlotte Magdelaine-Beuzelin; Séverine Vermeire; Margaret Goodall; Filip Baert; Maja Noman; Gert Van Assche; Marc Ohresser; Danielle Degenne; Jean-Michel Dugoujon; Roy Jefferis; Paul Rutgeerts; Marie-Paule Lefranc; Hervé Watier
IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab.
Pharmacogenetics and genomics 2009;19(5):383-7.
2009: Mirjam Bueno de Mesquita; Marc Ferrante; Liesbet Henckaerts; Marie Joossens; Virginie Janssens; Tibor Hlavaty; Marie Pierik; Sofie Joossens; Nele Van Schuerbeek; Gert van Assche; Paul Rutgeerts; Severine Vermeire; Ilse Hoffman
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease.
European journal of pediatrics 2009;168(5):575-83.
2009: Paul Rutgeerts; Severine Vermeire; Gert van Assche
Biological therapies for inflammatory bowel diseases.
Gastroenterology 2009;136(4):1182-97.
2009: H Fidder; F Schnitzler; Marc Ferrante; Maja Noman; K Katsanos; Siegfried Segaert; Liesbet Henckaerts; Gert van Assche; Severine Vermeire; Paul Rutgeerts
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.
Gut 2009;58(4):501-8.
2009: F Schnitzler; H Fidder; Marc Ferrante; Maja Noman; I Arijs; Gert van Assche; Ilse Hoffman; Kristel van Steen; Severine Vermeire; Paul Rutgeerts
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
Gut 2009;58(4):492-500.
2009: Severine Vermeire; Gert van Assche; Paul Rutgeerts
Genetic analysis to predict prognosis at the onset of Crohn's disease: not yet ready for prime time?
Gut 2009;58(3):323-4.
2009: Rinse K Weersma; Pieter C F Stokkers; Isabelle Cleynen; Simone C S Wolfkamp; Liesbet Henckaerts; Stefan Schreiber; Gerard Dijkstra; Andre Franke; Ilja M Nolte; Paul Rutgeerts; Cisca Wijmenga; Severine Vermeire
Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
The American journal of gastroenterology 2009;104(3):630-8.
2009: Vicky De Preter; Veerle Bulteel; Peter Suenaert; Karen Paula Geboes; Gert De Hertogh; Anja Luypaerts; Karel Geboes; Kristin Verbeke; Paul Rutgeerts
Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.
Inflammatory bowel diseases 2009;15(3):335-40.
2009: Vicky De Preter; Greet Van Staeyen; Diederik Esser; Paul Rutgeerts; Kristin Verbeke
Development of a screening method to determine the pattern of fermentation metabolites in faecal samples using on-line purge-and-trap gas chromatographic-mass spectrometric analysis.
Journal of chromatography. A 2009;1216(9):1476-83.
2009: Marc Ferrante; Séverine Vermeire; Gert van Assche; Paul Rutgeerts
Reply to Dr. Caprilli et al.'s letter.
Journal of Crohn's & colitis 2009;3(1):45.
2009: Peter Bossuyt; Jan Verhaegen; Gert van Assche; Paul Rutgeerts; Séverine Vermeire
Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease.
Journal of Crohn's & colitis 2009;3(1):4-7.
2009: Ingrid Arijs; Gert De Hertogh; Katleen Lemaire; Roel Quintens; Leentje Van Lommel; Kristel van Steen; Peter Leemans; Isabelle Cleynen; Gert van Assche; Severine Vermeire; Karel Geboes; Frans Schuit; Paul Rutgeerts
Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.
PloS one 2009;4(11):e7984.
2009: Alexandra-Chloé Villani; Mathieu Lemire; Edouard Louis; Mark S Silverberg; Catherine Collette; Geneviève Fortin; Elaine R Nimmo; Yannick Renaud; Sébastien Brunet; Cecile Libioulle; Jacques Belaiche; Alain Bitton; Daniel Gaudet; Albert Cohen; Diane Langelier; John D Rioux; Ian D R Arnott; Gary E Wild; Paul Rutgeerts; Jack Satsangi; Severine Vermeire; Thomas J Hudson; Denis Franchimont
Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.
PloS one 2009;4(9):e7154.
2009: Séverine Vermeire; Gert Van Assche; Paul Rutgeerts
Serum sickness, encephalitis and other complications of anti-cytokine therapy.
Best practice & research. Clinical gastroenterology 2009;23(1):101-12.
2009: Maureen J Koslowski; Irmgard Kübler; Mathias Chamaillard; Elke Schaeffeler; Walter Reinisch; Guoxing Wang; Julia Beisner; Alexander Teml; Laurent Peyrin-Biroulet; Stefan Winter; Klaus R Herrlinger; Paul Rutgeerts; Séverine Vermeire; Rachel Cooney; Klaus Fellermann; Derek Jewell; Charles L Bevins; Matthias Schwab; Eduard F Stange; Jan Wehkamp
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
PloS one 2009;4(2):e4496.
2009: Alexandra-Chloé Villani; Mathieu Lemire; Geneviève Fortin; Edouard Louis; Mark S Silverberg; Catherine Collette; Nobuyasu Baba; Cecile Libioulle; Jacques Belaiche; Alain Bitton; Daniel Gaudet; Albert Cohen; Diane Langelier; Paul R Fortin; Joan E Wither; Marika Sarfati; Paul Rutgeerts; John D Rioux; Severine Vermeire; Thomas J Hudson; Denis Franchimont
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.
Nature genetics 2009;41(1):71-6.
2009: Liesbet Henckaerts; Kaspar R Nielsen; Rudi Steffensen; Kristel van Steen; Chantal Mathieu; Annapaula Giulietti; Pieter J Wouters; Ilse Milants; Ilse Vanhorebeek; Lies Langouche; Séverine Vermeire; Paul Rutgeerts; Steffen Thiel; Alexander Wilmer; Troels Krarup Hansen; Greet Van den Berghe
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit.
Critical care medicine 2009;37(1):192-201, e1-3.
2009: Liesbet Henckaerts; Martine Jaspers; Werner Van Steenbergen; Liesbet Vliegen; Johan Fevery; Hilde Nuytten; Tania Roskams; Paul Rutgeerts; Jean-Jacques Cassiman; Severine Vermeire; Harry Cuppens
Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
Journal of hepatology 2009;50(1):150-7.
2008: Gert van Assche; Séverine Vermeire; Paul Rutgeerts
Management of loss of response to anti-TNF drugs: Change the dose or change the drug?
Journal of Crohn's & colitis 2008;2(4):348-51.
2008: Gert Van Assche; Séverine Vermeire; Paul Rutgeerts
Optimizing treatment of inflammatory bowel diseases with biologic agents.
Current gastroenterology reports 2008;10(6):591-6.
2008: Andre Franke; Tobias Balschun; Tom H Karlsen; Jurgita Sventoraityte; Susanna Nikolaus; Gabriele Mayr; Francisco S Domingues; Mario Albrecht; Michael Nothnagel; David Ellinghaus; Christian Sina; Clive M Onnie; Rinse Weersma; Pieter C F Stokkers; Cisca Wijmenga; Maria Gazouli; David Strachan; Wendy L McArdle; Séverine Vermeire; Paul Rutgeerts; Philip Rosenstiel; Michael Krawczak; Morten Vatn; Christopher G Mathew; Stefan Schreiber
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.
Nature genetics 2008;40(11):1319-23.
2008: C Breynaert; Severine Vermeire; Paul Rutgeerts; Gert van Assche
Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Acta gastro-enterologica Belgica 2008;71(4):367-72.
2008: Gert van Assche; Séverine Vermeire; Paul Rutgeerts
What can we expect from endoscopic dilation of the stenotic tract in Crohn's disease?
Inflammatory bowel diseases 2008;14 Suppl 2():S275-6.
2008: Severine Vermeire; Gert van Assche; Paul Rutgeerts
Should family members of IBD patients be screened for CARD15/NOD2 mutations?
Inflammatory bowel diseases 2008;14 Suppl 2():S190-1.
2008: Paul Rutgeerts; Severine Vermeire; Gert van Assche
What is the role of endoscopy in predicting Crohn's disease relapse or course?
Inflammatory bowel diseases 2008;14 Suppl 2():S183-4.
2008: Paul Rutgeerts; Gert van Assche
What is the role of endoscopy in the postoperative management of Crohn's disease?
Inflammatory bowel diseases 2008;14 Suppl 2():S179-80.
2008: Geert D'Haens; Severine Vermeire; Gert van Assche; Maja Noman; Isolde Aerden; Gust Van Olmen; Paul Rutgeerts
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
Gastroenterology 2008;135(4):1123-9.
2008: William J Sandborn; Brian G Feagan; Richard N Fedorak; Ellen Scherl; Mark R Fleisher; Seymour Katz; Jewel Johanns; Marion Blank; Paul Rutgeerts
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
Gastroenterology 2008;135(4):1130-41.
2008: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Treatment of severe steroid refractory ulcerative colitis.
World journal of gastroenterology : WJG 2008;14(36):5508-11.
2008: Marc Ferrante; Séverine Vermeire; Herma Fidder; Fabian Schnitzler; Maja Noman; Gert van Assche; Gert De Hertogh; Ilse Hoffman; Andre D'Hoore; Kristel van Steen; Karel Geboes; Freddy Penninckx; Paul Rutgeerts
Long-term outcome after infliximab for refractory ulcerative colitis.
Journal of Crohn's & colitis 2008;2(3):219-25.
2008: John Burke; Marc Ferrante; Karen Dejaegher; R William G Watson; Neil Docherty; Gert De Hertogh; Severine Vermeire; Paul Rutgeerts; Andre D'Hoore; Freddy Penninckx; Karel Geboes; Gert van Assche; Ronan O'Connell
Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease.
Inflammatory bowel diseases 2008;14(9):1197-204.
2008: Lieselotte Cloetens; Vicky De Preter; Katrien Swennen; Willem F Broekaert; Christophe M Courtin; Jan A Delcour; Paul Rutgeerts; Kristin Verbeke
Dose-response effect of arabinoxylooligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers.
Journal of the American College of Nutrition 2008;27(4):512-8.
2008: I Hoffman; Severine Vermeire; Gert van Assche; Paul Rutgeerts
Infliximab for pediatric Crohn's disease.
Drugs of today (Barcelona, Spain : 1998) 2008;44(8):615-28.
2008: Marc Ferrante; Sarah Declerck; Tamara Coopmans; Gert De Hertogh; Gert van Assche; Freddy Penninckx; Paul Rutgeerts; Karel Geboes; Andre D'Hoore; Séverine Vermeire
Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes.
Journal of Crohn's & colitis 2008;2(2):142-51.
2008: Lieselotte Cloetens; Vicky De Preter; Henriette de Loor; Paul Rutgeerts; Kristin Verbeke
Does the biomarker 15N-lactose ureide allow to estimate the site of fermentation of resistant starch?
European journal of nutrition 2008;47(4):217-23.
2008: Severine Vermeire; Nathalie Vermeulen; Gert van Assche; Xavier Bossuyt; Paul Rutgeerts
(Auto)antibodies in inflammatory bowel diseases.
Gastroenterology clinics of North America 2008;37(2):429-38, vii.
2008: Gert van Assche; Charlotte Magdelaine-Beuzelin; Geert D'Haens; Filip Baert; Maja Noman; Severine Vermeire; David Ternant; Hervé Watier; Gilles Paintaud; Paul Rutgeerts
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Gastroenterology 2008;134(7):1861-8.
2008: Brian G Feagan; William J Sandborn; Ulrich Mittmann; Simon Bar-Meir; Geert D'Haens; Marc Bradette; Albert Cohen; Chrystian Dallaire; Terry P Ponich; J W D McDonald; Xavier Hébuterne; Pierre Paré; Pavel Klvana; Yaron Niv; Sandro Ardizzone; Olga Alexeeva; Alaa Rostom; Gediminas Kiudelis; Johannes Spleiss; Denise Gilgen; Margaret K Vandervoort; Cindy J Wong; Guang Yong Zou; Allan Donner; Paul Rutgeerts
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.
JAMA : the journal of the American Medical Association 2008;299(14):1690-7.
2008: Peggy Vandewalle-El Khoury; Jean-Frédéric Colombel; Sofie Joossens; Annie Standaert-Vitse; Mayeul Collot; Jonas Halfvarson; Ali Ayadi; Carol J Landers; Severine Vermeire; Paul Rutgeerts; Stephan R Targan; Mathias Chamaillard; Jean-Maurice Mallet; Boualem Sendid; Daniel Poulain
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
The American journal of gastroenterology 2008;103(4):949-57.
2008: Vicky De Preter; Tom Vanhoutte; Geert Huys; Jean Swings; Paul Rutgeerts; Kristin Verbeke
Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects.
Alimentary pharmacology & therapeutics 2008;27(6):504-13.
2008: Nathalie Vermeulen; Ingrid Arijs; Sofie Joossens; Severine Vermeire; Stefan Clerens; Karolien Van den Bergh; Georges Michiels; Lutgarde Arckens; Frans Schuit; Leentje Van Lommel; Paul Rutgeerts; Xavier Bossuyt
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
Clinical chemistry 2008;54(3):534-41.
2008: Paul Rutgeerts; Stefan Schreiber; Brian Feagan; Dorothy L Keininger; Liz O'Neil; Richard N Fedorak
Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease.
International journal of colorectal disease 2008;23(3):289-96.
2008: Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van de Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Lancet 2008;371(9613):660-7.
2008: Vicky De Preter; H Raemen; L Cloetens; E Houben; Paul Rutgeerts; Kristin Verbeke
Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities.
European journal of clinical nutrition 2008;62(2):225-31.
2008: Gert van Assche; Séverine Vermeire; Paul Rutgeerts
Infliximab: the evidence for its place in therapy in ulcerative colitis.
Core evidence 2008;2(3):151-61.
2008: Marc Ferrante; Sarah Declerck; Gert De Hertogh; Gert van Assche; Karel Geboes; Paul Rutgeerts; Freddy Penninckx; Severine Vermeire; Andre D'Hoore
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
Inflammatory bowel diseases 2008;14(1):20-8.
2008: Harald Peeters; Bert Vander Cruyssen; Herman Mielants; kurt de vlam; Séverine Vermeire; Edouard Louis; Paul Rutgeerts; Jacques Belaiche; Martine De Vos
Clinical and genetic factors associated with sacroiliitis in Crohn's disease.
Journal of gastroenterology and hepatology 2008;23(1):132-7.
2007: Vinciane Dideberg; Gudlaug Kristjansdottir; Lili Milani; Cecile Libioulle; Snaevar Sigurdsson; Edouard Louis; Ann-Christin Wiman; Severine Vermeire; Paul Rutgeerts; Jacques Belaiche; Denis Franchimont; André Van Gossum; Vincent Bours; Ann-Christine Syvänen
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
Human molecular genetics 2007;16(24):3008-16.
2007: Severine Vermeire; Gert Van Assche; Paul Rutgeerts
Role of biomarkers in the diagnosis of inflammatory bowel disease.
Expert opinion on medical diagnostics 2007;1(4):481-8.
2007: Konstantinos Katsanos; Etienne Cavalier; Marc Ferrante; Valérie Van Hauwaert; Liesbet Henckaerts; Fabian Schnitzler; Afroditi Katsaraki; Maja Noman; Séverine Vermeire; Epameinondas V Tsianos; Paul Rutgeerts; Jean-Paul Chapelle; Gert van Assche
Intravenous iron therapy restores functional iron deficiency induced by infliximab.
Journal of Crohn's & colitis 2007;1(2):97-105.
2007: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Adalimumab in Crohn's disease.
Biologics : targets & therapy 2007;1(4):355-65.
2007: Liesbet Henckaerts; Marie Pierik; Marie Joossens; Marc Ferrante; Paul Rutgeerts; Severine Vermeire
Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
Gut 2007;56(11):1536-42.
2007: Vicky De Peter; Lieselotte Cloetens; Paul Rutgeerts; Kristin Verbeke
Influence of resistant starch alone or combined with wheat bran on gastric emptying and protein digestion in healthy volunteers.
Scandinavian journal of gastroenterology 2007;42(10):1187-93.
2007: Marc Ferrante; Liesbet Henckaerts; Marie Joossens; Marie Pierik; Sofie Joossens; Nir Dotan; Gary L Norman; Rom Altstock; Kristel van Steen; Paul Rutgeerts; Gert van Assche; Severine Vermeire
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
Gut 2007;56(10):1394-403.
2007: Walter Reinisch; William J Sandborn; Mohan Bala; Songkai Yan; Brian G Feagan; Paul Rutgeerts; Graham Radford-Smith; Stephen Xu; Debra Eisenberg; Allan Olson; Jean-Frédéric Colombel
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis.
Inflammatory bowel diseases 2007;13(9):1135-40.
2007: Joris Arts; Daniel Sifrim; Paul Rutgeerts; Antoon Lerut; Jozef Janssens; Jan Tack
Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease.
Digestive diseases and sciences 2007;52(9):2170-7.
2007: William J Sandborn; Stephen B Hanauer; Paul Rutgeerts; R N Fedorak; M Lukas; D G MacIntosh; Remo Panaccione; D Wolf; J D Kent; B Bittle; J Li; Paul F Pollack
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Gut 2007;56(9):1232-9.
2007: Severine Vermeire; Maja Noman; Gert van Assche; Filip Baert; Geert D'Haens; Paul Rutgeerts
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.
Gut 2007;56(9):1226-31.
2007: William J Sandborn; Brian G Feagan; Simeon Stoinov; Pieter J Honiball; Paul Rutgeerts; David Mason; Ralph Bloomfield; Stefan Schreiber
Certolizumab pegol for the treatment of Crohn's disease.
The New England journal of medicine 2007;357(3):228-38.
2007: Michael Clark; Jean-Frédéric Colombel; Brian C Feagan; Richard N Fedorak; Stephen B Hanauer; Michael A Kamm; Lloyd Mayer; Carol Regueiro; Paul Rutgeerts; William J Sandborn; Bruce Sands; Stefan Schreiber; Stephan R Targan; Simon Travis; Severine Vermeire
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
Gastroenterology 2007;133(1):312-39.
2007: Herbert J Van Kruiningen; Marie Joossens; Severine Vermeire; Sofie Joossens; Stéphane Debeugny; Corinne Gower-Rousseau; Antoine Cortot; Jean-Frédéric Colombel; Paul Rutgeerts; Robert Francois Vlietinck
Familial Crohn's disease in Belgium: pedigrees, temporal relationships among cases, and family histories.
Journal of clinical gastroenterology 2007;41(6):583-90.
2007: William J Sandborn; Paul Rutgeerts; Robert Enns; Stephen B Hanauer; Jean-Frédéric Colombel; Remo Panaccione; Geert D'Haens; Ju Li; Marie R Rosenfeld; Jeffrey D Kent; Paul F Pollack
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Annals of internal medicine 2007;146(12):829-38.
2007: Liesbet Henckaerts; Johan Fevery; Werner Van Steenbergen; Chris Verslype; Frederik Nevens; Paul Yap; Tania Roskams; Paul Rutgeerts; Severine Vermeire
The RANTES -28 g polymorphism is associated with primary sclerosing cholangitis.
Gut 2007;56(6):891-2.
2007: Marie Joossens; Marc Simoens; Severine Vermeire; Xavier Bossuyt; Karel Geboes; Paul Rutgeerts
Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases.
Inflammatory bowel diseases 2007;13(5):580-4.
2007: Cecile Libioulle; Edouard Louis; Sarah Hansoul; Cynthia Sandor; Frédéric Farnir; Denis Franchimont; Severine Vermeire; olivier dewit; Martine De Vos; Anna Dixon; Bruno Demarche; Ivo Gut; Simon Heath; Mario Foglio; Liming Liang; Debby Laukens; Myriam Mni; Diana Zelenika; André Van Gossum; Paul Rutgeerts; Jacques Belaiche; Mark Lathrop; Michel Georges
Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4.
PLoS genetics 2007;3(4):e58.
2007: Paul Rutgeerts; Severine Vermeire; Gert van Assche
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
Gut 2007;56(4):453-5.
2007: Brian G Feagan; Walter Reinisch; Paul Rutgeerts; William J Sandborn; Songkai Yan; Debra Eisenberg; Mohan Bala; Jewel Johanns; Allan Olson; Stephen B Hanauer
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
The American journal of gastroenterology 2007;102(4):794-802.
2007: Tibor Hlavaty; Marc Ferrante; Liesbet Henckaerts; Marie Pierik; Paul Rutgeerts; Severine Vermeire
Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors.
Inflammatory bowel diseases 2007;13(4):372-9.
2007: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Endoscopic therapy of strictures in Crohn's disease.
Inflammatory bowel diseases 2007;13(3):356-8; discussion 362-3.
2007: Chong Shen; Gert De Hertogh; dominique ma bullens; Gert van Assche; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization?
Inflammatory bowel diseases 2007;13(3):308-16.
2007: Geert D'Haens; William J Sandborn; Brian G Feagan; Karel Geboes; Stephen B Hanauer; E Jan Irvine; Marc Lémann; Philippe Marteau; Paul Rutgeerts; Jurgen Schölmerich; Lloyd R Sutherland
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Gastroenterology 2007;132(2):763-86.
2007: Marc Ferrante; Severine Vermeire; Konstantinos Katsanos; Maja Noman; Gert van Assche; Fabian Schnitzler; Ingrid Arijs; Gert De Hertogh; Ilse Hoffman; J Karel Geboes; Paul Rutgeerts
Predictors of early response to infliximab in patients with ulcerative colitis.
Inflammatory bowel diseases 2007;13(2):123-8.
2007: Sarah Lebeer; Jan L Ceuppens; Karel Geboes; G Van Assche; Paul Rutgeerts; Jos Vanderleyden; Sigrid C J De Keersmaecker
Mechanisms of probiotic-host interaction with IBD as a case study: a role for exopolysaccharides?
Communications in agricultural and applied biological sciences 2007;72(1):41-5.
2007: Jean-Frédéric Colombel; William J Sandborn; Paul Rutgeerts; Robert Enns; Stephen B Hanauer; Remo Panaccione; Stefan Schreiber; Dan Byczkowski; Ju Li; Jeffrey D Kent; Paul F Pollack
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Gastroenterology 2007;132(1):52-65.
2007: Chong Shen; Ellen Dillissen; Ahmad Kasran; Yuan Lin; Jean Herman; Ilse Sienaert; Steven De Jonghe; Luk Kerremans; Karel Geboes; Louis Boon; Paul Rutgeerts; Jan L Ceuppens
Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice.
Clinical immunology (Orlando, Fla.) 2007;122(1):53-61.
2007: Vicky De Preter; Tom Vanhoutte; Geert Huys; Jean Swings; Luc De Vuyst; Paul Rutgeerts; Kristin Verbeke
Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans.
American journal of physiology. Gastrointestinal and liver physiology 2007;292(1):G358-68.
2006: Vicky De Preter; Tamara Coopmans; Paul Rutgeerts; Kristin Verbeke
Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects.
Journal of the American College of Nutrition 2006;25(6):541-9.
2006: Karen P Geboes; Gert De Hertogh; Vicky De Preter; Anja Luypaerts; Bert Bammens; Pieter Evenepoel; Yvo Ghoos; Karel Geboes; Paul Rutgeerts; Kristin Verbeke
The influence of inulin on the absorption of nitrogen and the production of metabolites of protein fermentation in the colon.
The British journal of nutrition 2006;96(6):1078-86.
2006: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapies.
Gastroenterology clinics of North America 2006;35(4):743-56.
2006: Gert van Assche; William J Sandborn; Brian G Feagan; Bruce A Salzberg; D Silvers; P S Monroe; W M Pandak; F H Anderson; John Valentine; G E Wild; D J Geenen; R Sprague; S R Targan; Paul Rutgeerts; V Vexler; D Young; R S Shames
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial.
Gut 2006;55(11):1568-74.
2006: Marc Ferrante; Freddy Penninckx; Gert De Hertogh; Karel Geboes; Andre D'Hoore; Maja Noman; Severine Vermeire; Paul Rutgeerts; Gert van Assche
Protein-losing enteropathy in Crohn's disease.
Acta gastro-enterologica Belgica 2006;69(4):384-9.
2006: Vinciane Dideberg; Emilie Théâtre; Frédéric Farnir; Severine Vermeire; Paul Rutgeerts; Martine De Vos; Jacques Belaiche; Denis Franchimont; André Van Gossum; Edouard Louis; Vincent Bours
The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease.
Pharmacogenetics and genomics 2006;16(10):727-34.
2006: Paul Rutgeerts
Review article: recurrence of Crohn's disease after surgery - the need for treatment of new lesions.
Alimentary pharmacology & therapeutics 2006;24 Suppl 3():29-32.
2006: Marc Ferrante; Marie Pierik; Liesbet Henckaerts; Marie Joossens; Karolien Claes; Nele Van Schuerbeek; Robert Francois Vlietinck; Paul Rutgeerts; Gert van Assche; Severine Vermeire
The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease.
Inflammatory bowel diseases 2006;12(9):870-8.
2006: Martin H Holtmann; Frank Krummenauer; Christina Claas; Kristina Kremeyer; Dirk Lorenz; Olivia Rainer; Iris Vogel; Ulrich Böcker; Stephan Böhm; Carsten Büning; Rainer Duchmann; Guido Gerken; Hans Herfarth; Norbert Lügering; Wolfgang Kruis; Max Reinshagen; Jan Schmidt; Andreas Stallmach; Jürgen Stein; Andreas Sturm; Peter R Galle; Daan W Hommes; Geert D'Haens; Paul Rutgeerts; Markus F Neurath
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.
Digestive diseases and sciences 2006;51(9):1516-24.
2006: Chong Shen; Ellen Dillissen; Ahmad Kasran; Yuan Lin; Gavin Clydesdale; Ilse Sienaert; Steven De Jonghe; Ling-Jie Gao; Karel Geboes; Louis Boon; Paul Rutgeerts; Jan L Ceuppens
Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(8):575-82.
2006: Silvija Cukovic-Cavka; Severine Vermeire; Irena Hrstic; Greet Claessens; Sanja Kolacek; Jasminka Jakic-Razumovic; Zeljko Krznaric; Katja Grubelic; Davor Radic; Zrinjka Misak; Oleg Jadresin; Paul Rutgeerts; Boris Vucelic
NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.
European journal of gastroenterology & hepatology 2006;18(8):895-9.
2006: Gert De Hertogh; Jeroen Aerssens; Ronald de Hoogt; P Peeters; Peter Verhasselt; Peter Van Eyken; Nadine Ectors; Severine Vermeire; Paul Rutgeerts; Bernard Coulie; Karel Geboes
Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.
The Journal of pathology 2006;209(4):532-9.
2006: Paul Rutgeerts; William J Sandborn; Richard N Fedorak; Daniel Rachmilewitz; Dino Tarabar; Peter Gibson; Ole Haagen Nielsen; Gary Wild; Stefan Schreiber; Claudia Pena Rossi; Monia Zignani
Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(7):888-93.
2006: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Safety issues with biological therapies for inflammatory bowel disease.
Current opinion in gastroenterology 2006;22(4):370-6.
2006: Marie Pierik; Paul Rutgeerts; Robert Francois Vlietinck; Severine Vermeire
Pharmacogenetics in inflammatory bowel disease.
World journal of gastroenterology : WJG 2006;12(23):3657-67.
2006: David N Moskovitz; Gert van Assche; Benedikte Maenhout; Joris Arts; Marc Ferrante; Severine Vermeire; Paul Rutgeerts
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(6):760-5.
2006: Marc Ferrante; Gert De Hertogh; Tibor Hlavaty; Geert D'Haens; Freddy Penninckx; Andre D'Hoore; Severine Vermeire; Paul Rutgeerts; Karel Geboes; Gert van Assche
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence.
Gastroenterology 2006;130(6):1595-606.
2006: Péter Lakatos; Simon Fischer; Karolien Claes; Agota Kovacs; Tamas Molnar; István Altorjay; Pal Demeter; Zsolt Tulassay; Károly Palatka; Mária Papp; Paul Rutgeerts; Ferenc Szalay; Janos Papp; Severine Vermeire; Laszlo Lakatos
DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.
Inflammatory bowel diseases 2006;12(5):362-8.
2006: Vinciane Dideberg; Edouard Louis; Frédéric Farnir; Sabrina Bertoli; Severine Vermeire; Paul Rutgeerts; Martine De Vos; André Van Gossum; Jacques Belaiche; Vincent Bours
Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study.
Pharmacogenetics and genomics 2006;16(5):369-73.
2006: Sofie Joossens; Marie Pierik; A Rector; Severine Vermeire; Marc Van Ranst; Paul Rutgeerts; Xavier Bossuyt
Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease.
Gut 2006;55(5):746.
2006: P Stas; Andre D'Hoore; Gert van Assche; Karel Geboes; E Steenkiste; Freddy Penninckx; Paul Rutgeerts; Severine Vermeire
Miliary tuberculosis following infliximab therapy for Crohn disease: A case report and review of the literature.
Acta gastro-enterologica Belgica 2006;69(2):217-20.
2006: Liesbet Henckaerts; Johan Fevery; Werner Van Steenbergen; Chris Verslype; Paul Yap; Frederik Nevens; Tania Roskams; Louis Libbrecht; Paul Rutgeerts; Severine Vermeire
CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.
Inflammatory bowel diseases 2006;12(4):272-7.
2006: Vicky De Preter; Tom Vanhoutte; Geert Huys; Jean Swings; Paul Rutgeerts; Kristin Verbeke
Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects.
Alimentary pharmacology & therapeutics 2006;23(7):963-74.
2006: Severine Vermeire; Paul Rutgeerts
The changing face of treatment for Crohn's disease.
The British journal of surgery 2006;93(4):385-6.
2006: Tibor Hlavaty; Philippe Persoons; Severine Vermeire; Marc Ferrante; Marie Pierik; Gert van Assche; Paul Rutgeerts
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease.
Inflammatory bowel diseases 2006;12(3):199-204.
2006: Paul Rutgeerts; Robert H Diamond; Mohan Bala; Allan Olson; Gary R Lichtenstein; Weihang Bao; Kamlesh Patel; Douglas C Wolf; Michael A Safdi; Jean-Frédéric Colombel; Bret A Lashner; Stephen B Hanauer
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Gastrointestinal endoscopy 2006;63(3):433-42; quiz 464.
2006: Severine Vermeire; Gert van Assche; Paul Rutgeerts
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Gut 2006;55(3):426-31.
2006: Paul Rutgeerts; Gert van Assche; Severine Vermeire
Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
Alimentary pharmacology & therapeutics 2006;23(4):451-63.
2006: Stephen B Hanauer; William J Sandborn; Paul Rutgeerts; Richard N Fedorak; Milan Lukas; Donald MacIntosh; Remo Panaccione; Douglas Wolf; Paul F Pollack
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Gastroenterology 2006;130(2):323-33; quiz 591.
2006: Philippe Maerten; B S Kwon; Chong Shen; Gert De Hertogh; Pascal Cadot; dominique ma bullens; Lut Overbergh; Chantal Mathieu; Gert van Assche; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis.
Clinical and experimental immunology 2006;143(2):228-36.
2006: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Emerging biological treatments in inflammatory bowel diseases.
Digestive diseases (Basel, Switzerland) 2006;24(1-2):131-6.
2006: Chong Shen; Gert van Assche; Paul Rutgeerts; Jan L Ceuppens
Caspase activation and apoptosis induction by adalimumab: demonstration in vitro and in vivo in a chimeric mouse model.
Inflammatory bowel diseases 2006;12(1):22-8.
2006: Marie Pierik; Sofie Joossens; Kristel van Steen; Nele Van Schuerbeek; Robert Francois Vlietinck; Paul Rutgeerts; Severine Vermeire
Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases.
Inflammatory bowel diseases 2006;12(1):1-8.
2006: Stéphanie Willot; Severine Vermeire; Marc Ohresser; Paul Rutgeerts; Gilles Paintaud; Jacques Belaiche; Martine De Vos; André Van Gossum; Denis Franchimont; Jean-Fréderic Colombel; Hervé Watier; Edouard Louis
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease.
Pharmacogenetics and genomics 2006;16(1):37-42.
2005: Paul Rutgeerts; William J Sandborn; Brian G Feagan; Walter Reinisch; Allan Olson; Jewel Johanns; Suzanne Travers; Daniel Rachmilewitz; Stephen B Hanauer; Gary R Lichtenstein; Willem J S de Villiers; Daniel H Present; Bruce Sands; Jean-Frédéric Colombel
Infliximab for induction and maintenance therapy for ulcerative colitis.
The New England journal of medicine 2005;353(23):2462-76.
2005: Carmen Monica Preda; Severine Vermeire; Paul Rutgeerts; Sophie Joosens; Mircea Diculescu; Catalina Marica; Mihai Ciocirlan; Virginia Mirea; Alexandru Oproiu
Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
Romanian journal of gastroenterology 2005;14(4):357-60.
2005: Severine Vermeire; Marie Pierik; Tibor Hlavaty; Greet Claessens; Nele van Schuerbeeck; Sofie Joossens; Marc Ferrante; Liesbet Henckaerts; Mirjam Bueno de Mesquita; Robert Francois Vlietinck; Paul Rutgeerts
Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
Gastroenterology 2005;129(6):1845-53.
2005: Severine Vermeire; Gert van Assche; Paul Rutgeerts
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases.
Nature clinical practice. Gastroenterology & hepatology 2005;2(12):580-6.
2005: William J Sandborn; Jean-Frédéric Colombel; Roberts Enns; Brian G Feagan; Stephen B Hanauer; Ian Craig Lawrance; Remo Panaccione; Martin Sanders; Stefan Schreiber; Stephan R Targan; Sander J H van Deventer; Ronald Goldblum; Darrin Despain; Gary S Hogge; Paul Rutgeerts
Natalizumab induction and maintenance therapy for Crohn's disease.
The New England journal of medicine 2005;353(18):1912-25.
2005: Karel Geboes; Paul Rutgeerts; Ghislain Opdenakker; Allan Olson; Kamlesh Patel; Carrie L Wagner; Colleen W Marano
Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
Current medical research and opinion 2005;21(11):1741-54.
2005: Tibor Hlavaty; Marie Pierik; Liesbet Henckaerts; Marc Ferrante; Sofie Joossens; Nele Van Schuerbeek; Maja Noman; Paul Rutgeerts; Severine Vermeire
Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
Alimentary pharmacology & therapeutics 2005;22(7):613-26.
2005: Stefan Schreiber; Paul Rutgeerts; Richard N Fedorak; Munaa Khaliq-Kareemi; Michael A Kamm; Michel Boivin; Charles N Bernstein; Michael Staun; Ole Østergaard Thomsen; Alison Innes
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease.
Gastroenterology 2005;129(3):807-18.
2005: Sofie Joossens; Peter Suenaert; Maja Noman; Severine Vermeire; Paul Rutgeerts
Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability.
Inflammatory bowel diseases 2005;11(9):863-4.
2005: Philippe Maerten; Chong Shen; dominique ma bullens; Gert van Assche; Stefaan W Van Gool; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Effects of interleukin 4 on CD25+CD4+ regulatory T cell function.
Journal of autoimmunity 2005;25(2):112-20.
2005: Gert van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Severine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
The New England journal of medicine 2005;353(4):362-8.
2005: Ahmad Kasran; Louis Boon; C H Wortel; R A Hogezand; S Schreiber; E Goldin; Mark de Boer; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease.
Alimentary pharmacology & therapeutics 2005;22(2):111-22.
2005: Philippe Persoons; Severine Vermeire; Koen Demyttenaere; Benjamin Fischler; Joris Vandenberghe; Lukas Van Oudenhove; Marie Pierik; Tibor Hlavaty; Gert van Assche; Maja Noman; Paul Rutgeerts
The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
Alimentary pharmacology & therapeutics 2005;22(2):101-10.
2005: Peter Suenaert; Veerle Bulteel; Severine Vermeire; Maja Noman; Gert van Assche; Paul Rutgeerts
Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.
Inflammatory bowel diseases 2005;11(7):667-73.
2005: Gert van Assche; Severine Vermeire; Paul Rutgeerts
Medical treatment of inflammatory bowel diseases.
Current opinion in gastroenterology 2005;21(4):443-7.
2005: Marc Van Ranst; Marie Joossens; Sofie Joossens; Kristel van Steen; Marie Pierik; Severine Vermeire; Paul Rutgeerts
Crohn's disease and month of birth.
Inflammatory bowel diseases 2005;11(6):597-9.
2005: Chong Shen; Philippe Maerten; Karel Geboes; Gert van Assche; Paul Rutgeerts; Jan L Ceuppens
Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model.
Clinical immunology (Orlando, Fla.) 2005;115(3):250-9.
2005: W P D Lemahieu; Bart Maes; Kristin Verbeke; Paul Rutgeerts; Karel Geboes; Yves Vanrenterghem
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(6):1383-91.
2005: Karel Geboes; Vicky De Preter; Anja Luypaerts; Bert Bammens; Pieter Evenepoel; Yvo Ghoos; Paul Rutgeerts; Kristin Verbeke
Validation of lactose[15N,15N]ureide as a tool to study colonic nitrogen metabolism.
American journal of physiology. Gastrointestinal and liver physiology 2005;288(5):G994-9.
2005: Paul Rutgeerts; Gert van Assche; Severine Vermeire; Geert D'Haens; Filip Baert; Maja Noman; Isolde Aerden; Gert De Hertogh; Karel Geboes; Martin Hiele; Andre D'Hoore; Freddy Penninckx
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.
Gastroenterology 2005;128(4):856-61.
2005: Herbert J Van Kruiningen; Marie Joossens; Severine Vermeire; Sofie Joossens; Stéphane Debeugny; Corinne Gower-Rousseau; Antoine Cortot; Jean-Frédéric Colombel; Paul Rutgeerts; Robert Francois Vlietinck
Environmental factors in familial Crohn's disease in Belgium.
Inflammatory bowel diseases 2005;11(4):360-5.
2005: Carmen Monica Preda; Mircea Diculescu; Virginia Mirea; Catalin Marica; Severine Vermeire; Paul Rutgeerts; Alexandru Oproiu
Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
Romanian journal of gastroenterology 2005;14(1):23-6.
2005: Joris Arts; T Lerut; Paul Rutgeerts; Daniel Sifrim; Jozef Janssens; Jan Tack
A one-year follow-up study of endoluminal gastroplication (Endocinch) in GERD patients refractory to proton pump inhibitor therapy.
Digestive diseases and sciences 2005;50(2):351-6.
2005: Chong Shen; G V Assche; Stefaan Colpaert; Philippe Maerten; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept.
Alimentary pharmacology & therapeutics 2005;21(3):251-8.
2005: Gert Van Assche; Paul Rutgeerts
Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.
American journal of physiology. Gastrointestinal and liver physiology 2005;288(2):G169-74.
2005: Marie Pierik; Gert De Hertogh; Severine Vermeire; Gert van Assche; Peter Van Eyken; Sofie Joossens; Greet Claessens; Robert Francois Vlietinck; Paul Rutgeerts; Karel Geboes
Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease.
Gut 2005;54(2):223-7.
2005: Kristin Verbeke; Vicky De Preter; Karel Geboes; T Daems; Guy Van den Mooter; Pieter Evenepoel; Paul Rutgeerts
In vivo evaluation of a colonic delivery system using isotope techniques.
Alimentary pharmacology & therapeutics 2005;21(2):187-94.
2004: Sofie Joossens; Severine Vermeire; Kristel van Steen; Godelieve Godefridis; Greet Claessens; Marie Pierik; Robert Francois Vlietinck; Raymond Aerts; Paul Rutgeerts; Xavier Bossuyt
Pancreatic autoantibodies in inflammatory bowel disease.
Inflammatory bowel diseases 2004;10(6):771-7.
2004: Britta Van Meensel; Martin Hiele; Ilse Hoffman; Severine Vermeire; Paul Rutgeerts; Karel Geboes; Xavier Bossuyt
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.
Clinical chemistry 2004;50(11):2125-35.
2004: Marco Daperno; Geert D'Haens; Gert van Assche; Filip Baert; Philippe Bulois; Vincent Maunoury; Raffaello Sostegni; Rodolfo Rocca; Angelo Pera; Annemie Gevers; Jean-Yves Mary; Jean-Frédéric Colombel; Paul Rutgeerts
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Gastrointestinal endoscopy 2004;60(4):505-12.
2004: Roelof J Bennink; Marc Peeters; Paul Rutgeerts; Luc Mortelmans
Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1698-704.
2004: Anna Maria Wolf; Dominik Wolf; Holger Rumpold; Alexander R Moschen; Arthur Kaser; Peter Obrist; Dietmar Fuchs; Gerald Brandacher; Christiane Winkler; Karel Geboes; Paul Rutgeerts; Herbert Tilg
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.
Clinical immunology (Orlando, Fla.) 2004;113(1):47-55.
2004: Paul Rutgeerts
Review article: treatment of perianal fistulizing Crohn's disease.
Alimentary pharmacology & therapeutics 2004;20 Suppl 4():106-10.
2004: Nathalie Franchimont; V Putzeys; Julien Collette; Severine Vermeire; Paul Rutgeerts; Martine De Vos; André Van Gossum; Denis Franchimont; René Fiasse; Paul A Pelckmans; Michel Malaise; Jacques Belaiche; Edouard Louis
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
Alimentary pharmacology & therapeutics 2004;20(6):607-14.
2004: Filip Baert; Severine Vermeire; Maja Noman; Gert van Assche; Geert D'Haens; Paul Rutgeerts
Management of ulcerative colitis and Crohn's disease.
Acta clinica Belgica 2004;59(5):304-14.
2004: Severine Vermeire; Gert van Assche; Paul Rutgeerts
C-reactive protein as a marker for inflammatory bowel disease.
Inflammatory bowel diseases 2004;10(5):661-5.
2004: Stephen B Hanauer; Burton I Korelitz; Paul Rutgeerts; Mark A Peppercorn; Ronald A Thisted; Russell D Cohen; Daniel H Present
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Gastroenterology 2004;127(3):723-9.
2004: Philippe Maerten; Karel Geboes; Gert De Hertogh; Chong Shen; Pascal Cadot; dominique ma bullens; Gert van Assche; Freddy Penninckx; Paul Rutgeerts; Jan L Ceuppens
Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease.
Clinical immunology (Orlando, Fla.) 2004;112(3):239-46.
2004: Johan Poelmans; Louw Feenstra; Ingrid Demedts; Paul Rutgeerts; Jan Tack
The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms.
The American journal of gastroenterology 2004;99(8):1419-26.
2004: Sofie Joossens; Marco Daperno; Zakera Shums; Kristel van Steen; James A Goeken; Claudio Trapani; Gary L Norman; Godelieve Godefridis; Greet Claessens; Angelo Pera; Marie Pierik; Severine Vermeire; Paul Rutgeerts; Xavier Bossuyt
Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis.
Clinical chemistry 2004;50(8):1422-5.
2004: Marie Pierik; Severine Vermeire; K V Steen; Sofie Joossens; Greet Claessens; Robert Francois Vlietinck; Paul Rutgeerts
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
Alimentary pharmacology & therapeutics 2004;20(3):303-10.
2004: Stephen B Hanauer; Carrie L Wagner; Mohan Bala; Lloyd Mayer; Suzanne Travers; Robert H Diamond; Allan Olson; Warren Bao; Paul Rutgeerts
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(7):542-53.
2004: Klara Gijsbers; Gert van Assche; Sofie Joossens; Sofie Struyf; Paul Proost; Paul Rutgeerts; Karel Geboes; Jo Van Damme
CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
European journal of immunology 2004;34(7):1992-2000.
2004: Denis Franchimont; Severine Vermeire; Hakim El Housni; Marie Pierik; Kristel van Steen; Thierry Gustot; Eric Quertinmont; M Abramowicz; André Van Gossum; Jacques Devière; Paul Rutgeerts
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
Gut 2004;53(7):987-92.
2004: Severine Vermeire; Paul Rutgeerts; Kristel van Steen; Sofie Joossens; Greet Claessens; Marie Pierik; M Peeters; Robert Francois Vlietinck
Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis.
Gut 2004;53(7):980-6.
2004: Chong Shen; dominique ma bullens; Ahmad Kasran; Philippe Maerten; Louis Boon; johannes aerts; Gert van Assche; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
International immunopharmacology 2004;4(7):939-51.
2004: Gert van Assche; Paul Rutgeerts
Medical management of postoperative recurrence in Crohn's disease.
Gastroenterology clinics of North America 2004;33(2):347-60, x.
2004: Paul Rutgeerts; Gert van Assche; Severine Vermeire
Optimizing anti-TNF treatment in inflammatory bowel disease.
Gastroenterology 2004;126(6):1593-610.
2004: Karel Geboes; Bert Bammens; Anja Luypaerts; Ramon Malheiros; Johan Buyse; Pieter Evenepoel; Paul Rutgeerts; Kristin Verbeke
Validation of a new test meal for a protein digestion breath test in humans.
The Journal of nutrition 2004;134(4):806-10.
2004: L Marchal; Geert D'Haens; Gert van Assche; Severine Vermeire; Maja Noman; Marc Ferrante; Martin Hiele; M Bueno De Mesquita; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.
Alimentary pharmacology & therapeutics 2004;19(7):749-54.
2004: Joris Arts; Geert D'Haens; Miranda Zeegers; Gert van Assche; Martin Hiele; Andre D'Hoore; Freddy Penninckx; Severine Vermeire; Paul Rutgeerts
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.
Inflammatory bowel diseases 2004;10(2):73-8.
2004: Bruce Sands; Frank H Anderson; Charles N Bernstein; William Y Chey; Brian G Feagan; Richard N Fedorak; Michael A Kamm; Joshua R Korzenik; Bret A Lashner; Jane E Onken; Daniel Rachmilewitz; Paul Rutgeerts; Gary Wild; Douglas C Wolf; Paul A Marsters; Suzanne Travers; Marion A Blank; Sander J H van Deventer
Infliximab maintenance therapy for fistulizing Crohn's disease.
The New England journal of medicine 2004;350(9):876-85.
2004: Severine Vermeire; Paul Rutgeerts
Novel biological strategies in inflammatory bowel diseases.
Inflammatory bowel diseases 2004;10 Suppl 1():S44-51.
2004: Nele Esters; Marie Pierik; Kristel van Steen; Severine Vermeire; Greet Claessens; Sofie Joossens; Robert Francois Vlietinck; Paul Rutgeerts
Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease.
The American journal of gastroenterology 2004;99(2):299-305.
2004: Séverine Vermeire; Paul Rutgeerts
Antibody responses in Crohn's disease.
Gastroenterology 2004;126(2):601-4.
2004: Paul Rutgeerts; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; Stefan Schreiber; Jean-Frédéric Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Stephen B Hanauer
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
Gastroenterology 2004;126(2):402-13.
2004: Philippe Maerten; Chong Shen; Stefaan Colpaert; Zhanju Liu; dominique ma bullens; Gert van Assche; Freddy Penninckx; Karel Geboes; G Vanham; Paul Rutgeerts; Jan L Ceuppens
Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
Clinical and experimental immunology 2004;135(2):310-7.
2004: Gert van Assche; Karel Geboes; Paul Rutgeerts
Medical therapy for Crohn's disease strictures.
Inflammatory bowel diseases 2004;10(1):55-60.
2003: Herbert Tilg; Harald Vogelsang; Othmar Ludwiczek; Herbert Lochs; Arthur Kaser; J-F Colombel; H Ulmer; Paul Rutgeerts; S Krüger; A Cortot; Geert D'Haens; Marieluise Harrer; Christoph Gasche; Fritz Wrba; I Kuhn; Walter Reinisch
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.
Gut 2003;52(12):1728-33.
2003: Gert van Assche; Geert D'Haens; Maja Noman; Severine Vermeire; Martin Hiele; Katrien Asnong; Joris Arts; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.
Gastroenterology 2003;125(4):1025-31.
2003: Karel Geboes; Anja Luypaerts; Paul Rutgeerts; Kristin Verbeke
Inulin is an ideal substrate for a hydrogen breath test to measure the orocaecal transit time.
Alimentary pharmacology & therapeutics 2003;18(7):721-9.
2003: Susanna Nikolaus; Paul Rutgeerts; R Fedorak; A Hillary Steinhart; Gary E Wild; D Theuer; J Möhrle; Stefan Schreiber
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study.
Gut 2003;52(9):1286-90.
2003: W P D Lemahieu; Bart D Maes; Yvo Ghoos; Paul Rutgeerts; Kristin Verbeke; Yves Vanrenterghem
Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.
American journal of physiology. Gastrointestinal and liver physiology 2003;285(3):G470-82.
2003: Bert Bammens; Pieter Evenepoel; Paul Rutgeerts; Yvo Ghoos; Bart Maes
13C-breath tests in peritoneal dialysis patients: influence of dialysis fluids.
European journal of gastroenterology & hepatology 2003;15(8):931-2.
2003: Severine Vermeire; Maja Noman; Gert van Assche; Filip Baert; Kristel van Steen; Nele Esters; Sofie Joossens; Xavier Bossuyt; Paul Rutgeerts
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.
Gastroenterology 2003;125(1):32-9.
2003: Paul Rutgeerts; Sander J H van Deventer; S Schreiber
Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.
Alimentary pharmacology & therapeutics 2003;17(12):1435-50.
2003: Peter Suenaert; Veerle Bulteel; E Den Hond; benny geypens; F Monsuur; Anja Luypaerts; Yvo Ghoos; Paul Rutgeerts
In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.
Scandinavian journal of gastroenterology 2003;38(4):399-408.
2003: Maarten Thomeer; Iacopo Carbone; Hilde Bosmans; Gabriel Kiss; Didier Bielen; Dirk Vanbeckevoort; Eric Van Cutsem; Paul Rutgeerts; Guy Marchal
Stool tagging applied in thin-slice multidetector computed tomography colonography.
Journal of computer assisted tomography 2003;27(2):132-9.
2003: Didier Bielen; Maarten Thomeer; Dirk Vanbeckevoort; Gabriel Kiss; Frederik Maes; Guy Marchal; Paul Rutgeerts
Dry preparation for virtual CT colonography with fecal tagging using water-soluble contrast medium: initial results.
European radiology 2003;13(3):453-8.
2003: Filip Baert; Maja Noman; Severine Vermeire; Gert van Assche; Geert D' Haens; An Carbonez; Paul Rutgeerts
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
The New England journal of medicine 2003;348(7):601-8.
2003: Paul Rutgeerts
Strategies in the prevention of post-operative recurrence in Crohn's disease.
Best practice & research. Clinical gastroenterology 2003;17(1):63-73.
2003: Gert van Assche; Ignace Dalle; Maja Noman; Isolde Aerden; Caroline Swijsen; Katrien Asnong; Bart Maes; Jan L Ceuppens; Karel Geboes; Paul Rutgeerts
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.
The American journal of gastroenterology 2003;98(2):369-76.
2003: Gert van Assche; Dirk Vanbeckevoort; Didier Bielen; Georges Coremans; Isolde Aerden; Maja Noman; Andre D'Hoore; Freddy Penninckx; Guy Marchal; Freddy Cornillie; Paul Rutgeerts
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
The American journal of gastroenterology 2003;98(2):332-9.
2003: Subrata Ghosh; Eran Goldin; Fiona H Gordon; Helmut A Malchow; Jørgen Rask-Madsen; Paul Rutgeerts; Petr Vyhnálek; Zdena Zádorová; Tanya Palmer; Stephen Donoghue
Natalizumab for active Crohn's disease.
The New England journal of medicine 2003;348(1):24-32.
2003: Paul Rutgeerts
Modern therapy for inflammatory bowel disease.
Scandinavian journal of gastroenterology. Supplement 2003;(237):30-3.
2003: Paul Rutgeerts; Liesbeth Lemmens; Gert van Assche; Maja Noman; I Borghini-Fuhrer; Rene Goedkoop
Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study.
Alimentary pharmacology & therapeutics 2003;17(2):185-92.
2002: Gert van Assche; Filip Baert; Marc De Reuck; Martine De Vos; Olivier De Wit; Pierre Hoang; Edouard Louis; Fazia Mana; Paul A Pelckmans; Paul Rutgeerts; André Van Gossum; Geert D'Haens
The role of aminosalicylates in the treatment of ulcerative colitis.
Acta gastro-enterologica Belgica 2002;65(4):196-9.
2002: Stefaan Colpaert; Kathleen Vastraelen; Zhanju Liu; Philippe Maerten; Chong Shen; Freddy Penninckx; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
European cytokine network 2002;13(4):431-7.
2002: Yvo Ghoos; benny geypens; Paul Rutgeerts
Stable isotopes and 13CO2 breath tests for investigating gastrointestinal functions.
Food and nutrition bulletin 2002;23(3 Suppl):166-8.
2002: Severine Vermeire; Edouard Louis; An Carbonez; Gert van Assche; Maja Noman; Jacques Belaiche; Martine De Vos; André Van Gossum; Paul Pescatore; René Fiasse; Paul A Pelckmans; Hendrik Reynaert; Geert D'Haens; Paul Rutgeerts
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease.
The American journal of gastroenterology 2002;97(9):2357-63.
2002: Peter Suenaert; Veerle Bulteel; Liesbeth Lemmens; Maja Noman; benny geypens; Gert van Assche; Karel Geboes; Jan L Ceuppens; Paul Rutgeerts
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
The American journal of gastroenterology 2002;97(8):2000-4.
2002: Karel Geboes; B Maes; Anja Luypaerts; Pieter Evenepoel; Paul Rutgeerts; Yvo Ghoos; benny geypens
Magnesium chloride slows gastric emptying, but does not affect digestive functions.
Alimentary pharmacology & therapeutics 2002;16(8):1571-7.
2002: Edouard Louis; Severine Vermeire; Paul Rutgeerts; Martine De Vos; André Van Gossum; Paul Pescatore; René Fiasse; Paul A Pelckmans; Hendrik Reynaert; Geert D'Haens; Michel Malaise; Jacques Belaiche
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism.
Scandinavian journal of gastroenterology 2002;37(7):818-24.
2002: Gert van Assche; Paul Rutgeerts
Antiadhesion molecule therapy in inflammatory bowel disease.
Inflammatory bowel diseases 2002;8(4):291-300.
2002: Severine Vermeire; Edouard Louis; Paul Rutgeerts; Martine De Vos; André Van Gossum; Jacques Belaiche; Paul Pescatore; René Fiasse; Paul A Pelckmans; Robert Francois Vlietinck; Françoise Merlin; Habib Zouali; Gilles Thomas; Jean-Frédéric Colombel; Jean-Pierre Hugot
NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
Gastroenterology 2002;123(1):106-11.
2002: Nele Esters; Severine Vermeire; Sofie Joossens; Maja Noman; Edouard Louis; Jacques Belaiche; Martine De Vos; André Van Gossum; Paul Pescatore; René Fiasse; Paul A Pelckmans; Hendrik Reynaert; Daniel Poulain; Xavier Bossuyt; Paul Rutgeerts
Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.
The American journal of gastroenterology 2002;97(6):1458-62.
2002: Maarten Thomeer; Didier Bielen; Dirk Vanbeckevoort; Steven Dymarkowski; Anna-Maria Gevers; Paul Rutgeerts; M Hiele; Eric Van Cutsem; Guy Marchal
Patient acceptance for CT colonography: what is the real issue?
European radiology 2002;12(6):1410-5.
2002: Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean-Frédéric Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Lancet 2002;359(9317):1541-9.
2002: Sofie Joossens; Walter Reinisch; Severine Vermeire; Boualem Sendid; Daniel Poulain; Marc Peeters; Karel Geboes; Xavier Bossuyt; Peggy Vandewalle; Georg Oberhuber; Harald Vogelsang; Paul Rutgeerts; Jean-Frédéric Colombel
The value of serologic markers in indeterminate colitis: a prospective follow-up study.
Gastroenterology 2002;122(5):1242-7.
2002: Anna-Maria Gevers; Eric De Goede; Marc Simoens; Martin Hiele; Paul Rutgeerts
A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcers.
Gastrointestinal endoscopy 2002;55(4):466-9.
2002: Paul Rutgeerts
A critical assessment of new therapies in inflammatory bowel disease.
Journal of gastroenterology and hepatology 2002;17 Suppl():S176-85.
2002: William J Sandborn; Brian G Feagan; Stephen B Hanauer; Herbert Lochs; Robert Löfberg; Robert Modigliani; Daniel H Present; Paul Rutgeerts; Jurgen Schölmerich; Eduard F Stange; Lloyd R Sutherland
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
Gastroenterology 2002;122(2):512-30.
2002: Herbert Tilg; C van Montfrans; A van den Ende; Arthur Kaser; Sander J H van Deventer; S Schreiber; M Gregor; Othmar Ludwiczek; Paul Rutgeerts; Christoph Gasche; J C Koningsberger; L Abreu; I Kuhn; M Cohard; LeBeaut Pierre Alexandre; Paul C Grint; Günter Weiss
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma.
Gut 2002;50(2):191-5.
2002: Paul Rutgeerts
Current dilemmas in the management of inflammatory bowel disease.
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 2002;(587):58-61.
2002: Filip Baert; Alain Schmit; Geert D'Haens; Franceska Dedeurwaerdere; Edouard Louis; Marc Cabooter; Martine De Vos; Fernand Fontaine; Serge Naegels; Piet Schurmans; Hedwig Stals; Karel Geboes; Paul Rutgeerts
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up.
Gastroenterology 2002;122(1):20-5.
2002: Stefaan Colpaert; Kathleen Vanstraelen; Zhanju Liu; Freddy Penninckx; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease.
Clinical immunology (Orlando, Fla.) 2002;102(1):68-76.
2002: Bertrand Meresse; Paul Rutgeerts; Helmut A Malchow; Sylvain Dubucquoi; Jean-Paul Dessaint; M Cohard; Jean-Frédéric Colombel; Pierre Desreumaux
Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease.
Gut 2002;50(1):25-8.
2001: Stefaan Colpaert; Zhanju Liu; B De Greef; Paul Rutgeerts; Jan L Ceuppens; Karel Geboes
Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model.
Alimentary pharmacology & therapeutics 2001;15(11):1827-36.
2001: Geert D'Haens; C Swijsen; Maja Noman; Liesbeth Lemmens; Jan L Ceuppens; H Agbahiwe; Karel Geboes; Paul Rutgeerts
Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial.
The American journal of gastroenterology 2001;96(9):2564-8.
2001: Zhanju Liu; Karel Geboes; Peter W Hellings; Philippe Maerten; Hubertine Heremans; Peter Vandenberghe; Louis Boon; Peter van Kooten; Paul Rutgeerts; Jan L Ceuppens
B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1830-8.
2001: Jean-Frédéric Colombel; Paul Rutgeerts; Helmut A Malchow; M Jacyna; O H Nielsen; Jørgen Rask-Madsen; Sander J H van Deventer; A Ferguson; Pierre Desreumaux; A Forbes; K Geboes; L Melani; M Cohard
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease.
Gut 2001;49(1):42-6.
2001: Zhanju Liu; Karel Geboes; Hubertine Heremans; Lut Overbergh; Chantal Mathieu; Paul Rutgeerts; Jan L Ceuppens
Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
European journal of immunology 2001;31(5):1550-60.
2001: Paul Rutgeerts
Conventional treatment of Crohn's disease: objectives and outcomes.
Inflammatory bowel diseases 2001;7 Suppl 1():S2-8.
2001: Geert D'Haens; Liesbeth Lemmens; Karel Geboes; L Vandeputte; Frank Van Acker; Luc Mortelmans; M Peeters; Severine Vermeire; Freddy Penninckx; Frederik Nevens; Martin Hiele; Paul Rutgeerts
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.
Gastroenterology 2001;120(6):1323-9.
2001: Freddy Cornillie; D Shealy; Geert D'Haens; Karel Geboes; Gert van Assche; J Ceuppens; C Wagner; TF Schaible; Scott Plevy; Stephan R Targan; Paul Rutgeerts
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.
Alimentary pharmacology & therapeutics 2001;15(4):463-73.
2001: M Peeters; Sofie Joossens; Severine Vermeire; Robert Francois Vlietinck; Xavier Bossuyt; Paul Rutgeerts
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
The American journal of gastroenterology 2001;96(3):730-4.
2001: Severine Vermeire; Jack Satsangi; M Peeters; Miles Parkes; D P Jewell; Robert Francois Vlietinck; Paul Rutgeerts
Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.
Gastroenterology 2001;120(4):834-40.
2001: Severine Vermeire; S Joossens; M Peeters; F Monsuur; G Marien; Xavier Bossuyt; Peter Groenen; Robert Francois Vlietinck; Paul Rutgeerts
Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.
Gastroenterology 2001;120(4):827-33.
2001: Marc Simoens; Paul Rutgeerts
Non-variceal upper gastrointestinal bleeding.
Best practice & research. Clinical gastroenterology 2001;15(1):121-33.
2001: Severine Vermeire; M Peeters; Robert Francois Vlietinck; S Joossens; E Den Hond; Veerle Bulteel; Xavier Bossuyt; benny geypens; Paul Rutgeerts
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.
Inflammatory bowel diseases 2001;7(1):8-15.
2001: Paul Rutgeerts
The use of budesonide in the treatment of active Crohn's disease is good clinical practice.
Inflammatory bowel diseases 2001;7(1):60-61; discussion 62-3.
2001: Roelof J Bennink; M Peeters; G D'Haens; Paul Rutgeerts; Luc Mortelmans
Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of ulcerative colitis.
Clinical nuclear medicine 2001;26(2):99-104.
2001: Paul Rutgeerts; K Geboes
Understanding inflammatory bowel disease--the clinician's perspective.
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 2001;(586):66-72.
2000: Paul Rutgeerts; Severine Vermeire
Serological diagnosis of inflammatory bowel disease.
Lancet 2000;356(9248):2117-8.
2000: Richard N Fedorak; A Gangl; Charles O Elson; Paul Rutgeerts; S Schreiber; Gary Wild; Stephen B Hanauer; A Kilian; M Cohard; LeBeaut Pierre Alexandre; Brian G Feagan
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.
Gastroenterology 2000;119(6):1473-82.
2000: S Schreiber; Richard N Fedorak; O H Nielsen; Gary Wild; C N Williams; S Nikolaus; M Jacyna; B A Lashner; A Gangl; Paul Rutgeerts; Kim L Isaacs; Sander J H van Deventer; J C Koningsberger; M Cohard; LeBeaut Pierre Alexandre; Stephen B Hanauer
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
Gastroenterology 2000;119(6):1461-72.
2000: Filip Baert; Paul Rutgeerts
Medical therapies for ulcerative colitis and Crohn's disease.
Current gastroenterology reports 2000;2(6):446-50.
2000: Yvo Ghoos; benny geypens; Paul Rutgeerts
13CO2 breath tests and stable isotopes for investigating gastrointestinal functions.
Acta gastro-enterologica Belgica 2000;63(4):325-7.
2000: Paul Rutgeerts
Management of perianal Crohn's disease.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2000;14 Suppl C():7C-12C.
2000: Severine Vermeire; M Peeters; Robert Francois Vlietinck; Miles Parkes; Jack Satsangi; Derek Jewell; Paul Rutgeerts
Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.
Inflammatory bowel diseases 2000;6(3):165-70.
2000: Martin Hiele; Paul Rutgeerts
Combination therapies for the endoscopic treatment of gastrointestinal bleeding.
Baillière's best practice & research. Clinical gastroenterology 2000;14(3):459-66.
2000: Peter Suenaert; Veerle Bulteel; E Den Hond; Martin Hiele; M Peeters; F Monsuur; Yvo Ghoos; Paul Rutgeerts
The effects of smoking and indomethacin on small intestinal permeability.
Alimentary pharmacology & therapeutics 2000;14(6):819-22.
2000: Zhanju Liu; Karel Geboes; Stefaan Colpaert; Lut Overbergh; Chantal Mathieu; Hubertine Heremans; M de Boer; Louis Boon; GR D'Haens; Paul Rutgeerts; Jan L Ceuppens
Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(11):6005-14.
2000: Paul Rutgeerts
Infliximab is the drug we have been waiting for in Crohn's disease.
Inflammatory bowel diseases 2000;6(2):132-6.
2000: Anna-Maria Gevers; E Macken; Martin Hiele; Paul Rutgeerts
Endoscopic laser therapy for palliation of patients with distal colorectal carcinoma: analysis of factors influencing long-term outcome.
Gastrointestinal endoscopy 2000;51(5):580-5.
2000: Zhanju Liu; Karel Geboes; Stefaan Colpaert; GR D'Haens; Paul Rutgeerts; Jan L Ceuppens
IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(7):3608-15.
2000: M Craninx; Geert D'Haens; Kristof Cokelaere; Filip Baert; Freddy Penninckx; Andre D'Hoore; Nadine Ectors; Paul Rutgeerts; Karel Geboes
Crohn's disease and intestinal endometriosis: an intriguing co-existence.
European journal of gastroenterology & hepatology 2000;12(2):217-21.
2000: S Vermeire; M Peeters; Paul Rutgeerts
Diagnostic approach to IBD.
Hepato-gastroenterology 2000;47(31):44-8.
2000: Edouard Louis; M Peeters; Denis Franchimont; L Seidel; Fernand Fontaine; G Demolin; F Croes; P Dupont; L Davin; S Omri; Paul Rutgeerts; Jacques Belaiche
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
Clinical and experimental immunology 2000;119(1):64-8.
2000: Pieter Evenepoel; Martin Hiele; benny geypens; Karel Geboes; Paul Rutgeerts; Yvo Ghoos
13C-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine.
Gut 2000;46(1):52-7.
1999: R Bennink; M Peeters; V Van den Maegdenbergh; benny geypens; Paul Rutgeerts; MJ de Roo; Luc Mortelmans
Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women.
European journal of nuclear medicine 1999;26(12):1560-6.
1999: Bart D Maes; Johan Vanwalleghem; Dirk Kuypers; Yvo Ghoos; Paul Rutgeerts; Yves Vanrenterghem
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine.
Transplantation 1999;68(10):1482-5.
1999: Geert D'Haens; Paul Rutgeerts
Postoperative recurrence of Crohn's disease: pathophysiology and prevention.
Inflammatory bowel diseases 1999;5(4):295-303.
1999: Pieter Evenepoel; D Claus; benny geypens; Martin Hiele; Karel Geboes; Paul Rutgeerts; Yvo Ghoos
Amount and fate of egg protein escaping assimilation in the small intestine of humans.
The American journal of physiology 1999;277(5 Pt 1):G935-43.
1999: Geert D'Haens; Karel Geboes; Paul Rutgeerts
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine.
Gastrointestinal endoscopy 1999;50(5):667-71.
1999: Karel Geboes; P Desreumaux; A Jouret; Nadine Ectors; Paul Rutgeerts; J F Colombel
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
Gastroentérologie clinique et biologique 1999;23(10):1062-73.
1999: Paul Rutgeerts; F Baert
New strategies in the management of inflammatory bowel disease.
Acta clinica Belgica 1999;54(5):274-80.
1999: Karel Geboes; Paul Rutgeerts
Dysplasia in inflammatory bowel diseases: definition and clinical impact.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 1999;13(8):671-8.
1999: Paul Rutgeerts; Geert D'Haens; Stephan R Targan; Eric A Vasiliauskas; S B Hanauer; Daniel H Present; L Mayer; R A Van Hogezand; T Braakman; KL DeWoody; TF Schaible; Sander J H van Deventer
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Gastroenterology 1999;117(4):761-9.
1999: Zhanju Liu; Stefaan Colpaert; GR D'Haens; Ahmad Kasran; M de Boer; Paul Rutgeerts; Karel Geboes; Jan L Ceuppens
Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(7):4049-57.
1999: Paul Rutgeerts
Review article: efficacy of infliximab in Crohn's disease--induction and maintenance of remission.
Alimentary pharmacology & therapeutics 1999;13 Suppl 4():9-15; discussion 38.
1999: Paul Rutgeerts; S R Targan
Introduction: anti-TNF strategies in the treatment of Crohn's disease.
Alimentary pharmacology & therapeutics 1999;13 Suppl 4():1.
1999: benny geypens; R Bennink; M Peeters; Pieter Evenepoel; Luc Mortelmans; B Maes; Yvo Ghoos; Paul Rutgeerts
Validation of the lactose-[13C]ureide breath test for determination of orocecal transit time by scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(9):1451-5.
1999: Daniel H Present; Paul Rutgeerts; Stephan R Targan; S B Hanauer; L Mayer; Ruud A van Hogezand; D K Podolsky; Bruce Sands; T Braakman; KL DeWoody; TF Schaible; Sander J H van Deventer
Infliximab for the treatment of fistulas in patients with Crohn's disease.
The New England journal of medicine 1999;340(18):1398-405.
1999: E D Hond; M Peeters; Martin Hiele; Veerle Bulteel; Yvo Ghoos; Paul Rutgeerts
Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans.
Alimentary pharmacology & therapeutics 1999;13(5):679-85.
1999: Geert D'Haens; Sander J H van Deventer; R Van Hogezand; D Chalmers; C Kothe; Filip Baert; T Braakman; TF Schaible; Karel Geboes; Paul Rutgeerts
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
Gastroenterology 1999;116(5):1029-34.
1999: Marc Simoens; Anna-Maria Gevers; Paul Rutgeerts
Endoscopic therapy for upper gastrointestinal hemorrhage: a state of the art.
Hepato-gastroenterology 1999;46(26):737-45.
1999: Bart D Maes; Bernard Spitz; Yvo Ghoos; Martin Hiele; Pieter Evenepoel; Paul Rutgeerts
Gastric emptying in hyperemesis gravidarum and non-dyspeptic pregnancy.
Alimentary pharmacology & therapeutics 1999;13(2):237-43.
1999: L Vandeputte; Geert D'Haens; Filip Baert; Paul Rutgeerts
Methotrexate in refractory Crohn's disease.
Inflammatory bowel diseases 1999;5(1):11-5.
1999: E Den Hond; Martin Hiele; M Peeters; Yvo Ghoos; Paul Rutgeerts
Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease.
JPEN. Journal of parenteral and enteral nutrition 1999;23(1):7-11.
1999: Filip Baert; Geert D'Haens; M Peeters; Martin Hiele; TF Schaible; D Shealy; Karel Geboes; Paul Rutgeerts
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
Gastroenterology 1999;116(1):22-8.
1998: Paul Rutgeerts; F Baert
Immunosuppressive drugs in the treatment of Crohn's disease.
The European journal of surgery = Acta chirurgica 1998;164(12):911-5.
1998: Pieter Evenepoel; D Claus; benny geypens; B Maes; Martin Hiele; Paul Rutgeerts; Yvo Ghoos
Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy.
Alimentary pharmacology & therapeutics 1998;12(10):1011-9.
1998: Anna-Maria Gevers; E Macken; Martin Hiele; Paul Rutgeerts
A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula.
Gastrointestinal endoscopy 1998;48(4):383-8.
1998: Pieter Evenepoel; benny geypens; Anja Luypaerts; Martin Hiele; Yvo Ghoos; Paul Rutgeerts
Digestibility of cooked and raw egg protein in humans as assessed by stable isotope techniques.
The Journal of nutrition 1998;128(10):1716-22.
1998: J Tack; A M Gevers; Paul Rutgeerts
Self-expandable metallic stents in the palliation of rectosigmoidal carcinoma: a follow-up study.
Gastrointestinal endoscopy 1998;48(3):267-71.
1998: R Bennink; M Peeters; V Van den Maegdenbergh; benny geypens; Paul Rutgeerts; MJ de Roo; Luc Mortelmans
Comparison of total and compartmental gastric emptying and antral motility between healthy men and women.
European journal of nuclear medicine 1998;25(9):1293-9.
1998: E Den Hond; Martin Hiele; P Evenepoel; M Peeters; Yvo Ghoos; Paul Rutgeerts
In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis.
Gastroenterology 1998;115(3):584-90.
1998: Bart D Maes; G Mys; benny geypens; Pieter Evenepoel; Yvo Ghoos; Paul Rutgeerts
Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results.
The American journal of physiology 1998;275(1 Pt 1):G169-75.
1998: Geert D'Haens; A Verstraete; K Cheyns; Isolde Aerden; R Bouillon; Paul Rutgeerts
Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease.
Alimentary pharmacology & therapeutics 1998;12(5):419-24.
1998: Pieter Evenepoel; benny geypens; Paul Rutgeerts; Yvo Ghoos
Study of protein assimilation, using stable isotope techniques.
Revista de medicina de la Universidad de Navarra 1998;42(2):104-8.
1998: Bart D Maes; Martin Hiele; benny geypens; Yvo Ghoos; Paul Rutgeerts
Gastric emptying of the liquid, solid and oil phase of a meal in normal volunteers and patients with Billroth II gastrojejunostomy.
European journal of clinical investigation 1998;28(3):197-204.
1998: Geert D'Haens; Peter Suenaert; R Westhovens; Paul Rutgeerts
Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine.
Inflammatory bowel diseases 1998;4(1):27-8.
1998: Geert D'Haens; Karel Geboes; M Peeters; Filip Baert; Freddy Penninckx; Paul Rutgeerts
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.
Gastroenterology 1998;114(2):262-7.
1998: Paul Rutgeerts
The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
Mediators of inflammation 1998;7(3):137-40.
1998: Severine Vermeire; Paul Rutgeerts
[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].
Zentralblatt für Chirurgie 1998;123(4):352-6.
1998: E Macken; Anna-Maria Gevers; A Hendrickx; Paul Rutgeerts
Midazolam versus diazepam in lipid emulsion as conscious sedation for colonoscopy with or without reversal of sedation with flumazenil.
Gastrointestinal endoscopy 1998;47(1):57-61.
1997: Stephan R Targan; S B Hanauer; Sander J H van Deventer; L Mayer; Daniel H Present; T Braakman; KL DeWoody; TF Schaible; Paul Rutgeerts
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
The New England journal of medicine 1997;337(15):1029-35.
1997: Paul Rutgeerts; E Rauws; P Wara; P Swain; A Hoos; E Solleder; J Halttunen; G Dobrilla; G Richter; R Prassler
Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer.
Lancet 1997;350(9079):692-6.
1997: M Peeters; benny geypens; D Claus; H Nevens; Yvo Ghoos; G Verbeke; F Baert; S Vermeire; Robert Francois Vlietinck; Paul Rutgeerts
Clustering of increased small intestinal permeability in families with Crohn's disease.
Gastroenterology 1997;113(3):802-7.
1997: Geert D'Haens; Karel Geboes; M Peeters; Filip Baert; Nadine Ectors; Paul Rutgeerts
Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.
The American journal of gastroenterology 1997;92(8):1275-9.
1997: André Van Gossum; Alain Schmit; M Adler; C Chioccioli; René Fiasse; P Louwagie; Geert D'Haens; Paul Rutgeerts; Martine De Vos; Hendrik Reynaert; G Devis; Jacques Belaiche; Marc Van Outryve
Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group.
Acta gastro-enterologica Belgica 1997;60(3):197-200.
1997: benny geypens; D Claus; Pieter Evenepoel; Martin Hiele; B Maes; M Peeters; Paul Rutgeerts; Yvo Ghoos
Influence of dietary protein supplements on the formation of bacterial metabolites in the colon.
Gut 1997;41(1):70-6.
1997: Bart D Maes; Yvo Ghoos; Martin Hiele; Paul Rutgeerts
Gastric emptying rate of solids in patients with nonulcer dyspepsia.
Digestive diseases and sciences 1997;42(6):1158-62.
1997: Martin Hiele; Paul De Leyn; P Schurmans; Antoon Lerut; S Huys; Karel Geboes; Anna-Maria Gevers; Paul Rutgeerts
Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction.
Gastrointestinal endoscopy 1997;45(5):381-6.
1997: Geert D'Haens; Karel Geboes; E Ponette; Freddy Penninckx; Paul Rutgeerts
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease.
Gastroenterology 1997;112(5):1475-81.
1997: Pieter Evenepoel; Martin Hiele; Anja Luypaerts; benny geypens; Johan Buyse; E Decuypere; Paul Rutgeerts; Yvo Ghoos
Production of egg proteins, enriched with L-leucine-13C1, for the study of protein assimilation in humans using the breath test technique.
The Journal of nutrition 1997;127(2):327-31.
1997: Filip Baert; Paul Rutgeerts
Immunomodulator therapy of inflammatory bowel disease.
Acta clinica Belgica 1997;52(5):251-7.
1996: A Wilmer; Paul Rutgeerts
Push enteroscopy. Technique, depth, and yield of insertion.
Gastrointestinal endoscopy clinics of North America 1996;6(4):759-76.
1996: E Macken; Anna-Maria Gevers; Martin Hiele; Paul Rutgeerts
Treatment of esophagorespiratory fistulas with a polyurethane-covered self-expanding metallic mesh stent.
Gastrointestinal endoscopy 1996;44(3):324-6.
1996: M Peeters; H Nevens; F Baert; Martin Hiele; A M de Meyer; Robert Francois Vlietinck; Paul Rutgeerts
Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics.
Gastroenterology 1996;111(3):597-603.
1996: Robert Löfberg; Paul Rutgeerts; H Malchow; C Lamers; A Danielsson; G Olaison; D Jewell; O Ostergaard Thomsen; H Lorenz-Meyer; H Goebell; H Hodgson; Tore Persson; C Seidegård
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.
Gut 1996;39(1):82-6.
1996: Francesco Perri; Yvo Ghoos; B D Maes; benny geypens; Nadine Ectors; Karel Geboes; Martin Hiele; Paul Rutgeerts
Gastric emptying and Helicobacter pylori infection in duodenal ulcer disease.
Digestive diseases and sciences 1996;41(3):462-8.
1996: Severine Vermeire; Paul Rutgeerts
Cyclosporine monotherapy is effective in the treatment of severe ulcerative colitis.
Inflammatory bowel diseases 1996;2(4):253-4.
1996: M Peeters; Paul Rutgeerts
The negative association between appendectomy and ulcerative colitis reflects causal relationship.
Inflammatory bowel diseases 1996;2(3):214-6.
1996: B D Maes; Yvo Ghoos; benny geypens; Martin Hiele; Paul Rutgeerts
Relation between gastric emptying rate and rate of intraluminal lipolysis.
Gut 1996;38(1):23-7.
1995: Francesco Perri; B Maes; benny geypens; Yvo Ghoos; Martin Hiele; Paul Rutgeerts
The influence of isolated doses of drugs, feeding and colonic bacterial ureolysis on urea breath test results.
Alimentary pharmacology & therapeutics 1995;9(6):705-9.
1995: Frederik Nevens; L Broeckaert; Paul Rutgeerts; Werner Van Steenbergen; Johan Fevery
The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.
Hepato-gastroenterology 1995;42(6):979-84.
1995: Eric Van Cutsem; S Tejpar; Paul Rutgeerts; Jozef Janssens
Screening for colorectal cancer.
Acta gastro-enterologica Belgica 1995;58(5-6):397-404.
1995: Paul Rutgeerts; Martin Hiele; Karel Geboes; M Peeters; Freddy Penninckx; Raymond Aerts; R Kerremans
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.
Gastroenterology 1995;108(6):1617-21.
1995: Karel Geboes; Paul Rutgeerts
CD44v6 and CD44v3 variants in inflammatory bowel disease.
Lancet 1995;345(8959):1191-2.
1995: H Couckuyt; Anna-Maria Gevers; Georges Coremans; Martin Hiele; Paul Rutgeerts
Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: a prospective longterm analysis.
Gut 1995;36(4):577-80.
1995: B D Maes; Yvo Ghoos; benny geypens; Martin Hiele; Paul Rutgeerts
Relation between gastric emptying rate and energy intake in children compared with adults.
Gut 1995;36(2):183-8.
1995: B D Maes; Yvo Ghoos; benny geypens; Martin Hiele; Paul Rutgeerts
Influence of octreotide on the gastric emptying of solids and liquids in normal healthy subjects.
Alimentary pharmacology & therapeutics 1995;9(1):11-8.
1995: W E Peetermans; Geert D'Haens; Jan L Ceuppens; Paul Rutgeerts; Karel Geboes
Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease.
Gastroenterology 1995;108(1):75-82.
1994: B D Maes; Yvo Ghoos; Paul Rutgeerts; Martin Hiele; benny geypens; G Vantrappen
[*C]octanoic acid breath test to measure gastric emptying rate of solids.
Digestive diseases and sciences 1994;39(12 Suppl):104S-106S.
1994: G Vergote; E Ponette; Johny Verschakelen; AL Baert; Paul Rutgeerts; Philippe Moerman
Esophageal metastasis from breast carcinoma.
Journal belge de radiologie 1994;77(6):268-9.
1994: Geert D'Haens; Martin Hiele; Paul Rutgeerts; K Geboes; J L Ceuppens
Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.
Gut 1994;35(12):1728-33.
1994: M Peeters; Martin Hiele; Yvo Ghoos; V Huysmans; Karel Geboes; G Vantrappen; Paul Rutgeerts
Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: need for standardisation.
Gut 1994;35(10):1404-8.
1994: M Peeters; Yvo Ghoos; B Maes; Martin Hiele; Karel Geboes; G Vantrappen; Paul Rutgeerts
Increased permeability of macroscopically normal small bowel in Crohn's disease.
Digestive diseases and sciences 1994;39(10):2170-6.
1994: Paul Rutgeerts; Robert Löfberg; H Malchow; C Lamers; G Olaison; D Jewell; A Danielsson; H Goebell; Ole Ostergaard Thomsen; H Lorenz-Meyer
A comparison of budesonide with prednisolone for active Crohn's disease.
The New England journal of medicine 1994;331(13):842-5.
1994: Anna-Maria Gevers; H Couckuyt; Georges Coremans; Martin Hiele; Paul Rutgeerts
Efficacy and safety of hydrostatic balloon dilation of ileocolonic Crohn's strictures. A prospective long-term analysis.
Acta gastro-enterologica Belgica 1994;57(5-6):320-2.
1994: Geert D'Haens; Paul Rutgeerts
Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
Acta gastro-enterologica Belgica 1994;57(5-6):311-3.
1994: Paul Rutgeerts
Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
The Netherlands journal of medicine 1994;45(2):60-4.
1994: B D Maes; Yvo Ghoos; benny geypens; G Mys; Martin Hiele; Paul Rutgeerts; G Vantrappen
Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(5):824-31.
1994: Paul Rutgeerts; Geert D'Haens; Martin Hiele; Karel Geboes; G Vantrappen
Appendectomy protects against ulcerative colitis.
Gastroenterology 1994;106(5):1251-3.
1994: G Heyvaert; Freddy Penninckx; Ludo Filez; Raymond Aerts; R Kerremans; Paul Rutgeerts
Restorative proctocolectomy in elective and emergency cases of ulcerative colitis.
International journal of colorectal disease 1994;9(2):73-6.
1994: Geert D'Haens; Paul Rutgeerts; Karel Geboes; G Vantrappen
The natural history of esophageal Crohn's disease: three patterns of evolution.
Gastrointestinal endoscopy 1994;40(3):296-300.
1994: Nadine Ectors; Karel Geboes; R M De Vos; H P Heidbuchel; Paul Rutgeerts; Valeer Desmet; G R Vantrappen
Whipple's disease: a histological, immunocytochemical, and electron microscopic study of the small intestinal epithelium.
The Journal of pathology 1994;172(1):73-9.
1993: Geert D'Haens; Y Breysem; Paul Rutgeerts; B van Besien; Karel Geboes; E Ponette; G Vantrappen
Proctitis and rectal stenosis induced by nonsteroidal antiinflammatory suppositories.
Journal of clinical gastroenterology 1993;17(3):207-12.
1993: Nadine Ectors; M F Dixon; Karel Geboes; Paul Rutgeerts; Valeer Desmet; G R Vantrappen
Granulomatous gastritis: a morphological and diagnostic approach.
Histopathology 1993;23(1):55-61.
1993: Paul Rutgeerts; Karel Geboes
Crohn's disease and pre-aphthoid lesions.
Lancet 1993;341(8858):1443-4.
1993: Yvo Ghoos; B D Maes; benny geypens; G Mys; Martin Hiele; Paul Rutgeerts; G Vantrappen
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.
Gastroenterology 1993;104(6):1640-7.
1993: Paul Rutgeerts; Anna-Maria Gevers; Martin Hiele; L Broeckaert; G Vantrappen
Endoscopic injection therapy to prevent rebleeding from peptic ulcers with a protruding vessel: a controlled comparative trial.
Gut 1993;34(3):348-50.
1992: Paul Rutgeerts; M Peeters; Karel Geboes; G Vantrappen
Infectious agents in inflammatory bowel disease.
Endoscopy 1992;24(6):565-7.
1992: Karel Geboes; Paul Rutgeerts; Nadine Ectors; J Mebis; Freddy Penninckx; G Vantrappen; Valeer Desmet
Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease.
Gastroenterology 1992;103(2):439-47.
1992: Martin Hiele; Yvo Ghoos; Paul Rutgeerts; G Vantrappen
Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
Digestive diseases and sciences 1992;37(7):1057-64.
1992: Nadine Ectors; Karel Geboes; R De Vos; H Heidbuchel; Paul Rutgeerts; V Desmet; G Vantrappen
Whipple's disease: a histological, immunocytochemical and electronmicroscopic study of the immune response in the small intestinal mucosa.
Histopathology 1992;21(1):1-12.
1992: Paul Rutgeerts; K Geboes; G Vantrappen; J Van Isveldt; M Peeters; F Penninckx; M Hiele
Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum.
Journal of clinical gastroenterology 1992;15(1):24-8.
1992: Y Breysem; J F Janssens; Georges Coremans; G Vantrappen; G Hendrickx; Paul Rutgeerts
Endoscopic balloon dilation of colonic and ileo-colonic Crohn's strictures: long-term results.
Gastrointestinal endoscopy 1992;38(2):142-7.
1992: Karel Geboes; Nadine Ectors; H Heidbuchel; Paul Rutgeerts; V Desmet; G Vantrappen
Whipple's disease: the value of upper gastrointestinal endoscopy for the diagnosis and follow-up.
Acta gastro-enterologica Belgica 1992;55(2):209-19.
1991: Paul Rutgeerts; G Vantrappen; Martin Hiele; Yvo Ghoos; C Onkelinx
Effects on bowel motility of misoprostol administered before and after meals.
Alimentary pharmacology & therapeutics 1991;5(5):533-42.
1991: Paul Rutgeerts; K Goboes; M Peeters; Martin Hiele; Freddy Penninckx; Raymond Aerts; R Kerremans; G Vantrappen
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.
Lancet 1991;338(8770):771-4.
1991: Paul Rutgeerts; G Vantrappen
[Gastroduodenal hemorrhage: endoscopic treatment].
Helvetica chirurgica acta 1991;58(1-2):7-19.
1991: Martin Hiele; Yvo Ghoos; Paul Rutgeerts; G Vantrappen; D Schoorens
Influence of nutritional substrates on the formation of volatiles by the fecal flora.
Gastroenterology 1991;100(6):1597-602.
1991: I Vanmoerkerke; Paul Rutgeerts; G Vantrappen
The role of laser therapy in the palliative treatment of esophageal cancer.
Journal belge de radiologie 1991;74(5):401-6.
1990: Paul Rutgeerts; Karel Geboes; G Vantrappen; J Beyls; R Kerremans; Martin Hiele
Predictability of the postoperative course of Crohn's disease.
Gastroenterology 1990;99(4):956-63.
1990: Karel Geboes; Nadine Ectors; H Heidbuchel; Paul Rutgeerts; V Desmet; G Vantrappen
Whipple's disease: endoscopic aspects before and after therapy.
Gastrointestinal endoscopy 1990;36(3):247-52.
1990: Eric Van Cutsem; Paul Rutgeerts; G Vantrappen
Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone.
Lancet 1990;335(8695):953-5.
1990: Martin Hiele; Yvo Ghoos; Paul Rutgeerts; G Vantrappen; K de Buyser
13CO2 breath test to measure the hydrolysis of various starch formulations in healthy subjects.
Gut 1990;31(2):175-8.
1989: Paul Rutgeerts; Karel Geboes; G Vantrappen
Experimental studies of injection therapy for severe nonvariceal bleeding in dogs.
Gastroenterology 1989;97(3):610-21.
1989: Paul Rutgeerts; G Vantrappen; L Broeckaert; Georges Coremans; Jozef Janssens; Martin Hiele
Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers.
Lancet 1989;1(8648):1164-7.
1989: Philippe Demaerel; E Ponette; F Lacquet; L Verbist; Paul Rutgeerts; AL Baert
The role of radiology in Campylobacter enterocolitis.
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1989;150(5):551-5.
1989: Paul Rutgeerts
Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
Alimentary pharmacology & therapeutics 1989;3(2):183-91.
1989: G R Vantrappen; Paul Rutgeerts; Yvo Ghoos; Martin Hiele
Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum.
Gastroenterology 1989;96(4):1126-34.
1989: Martin Hiele; Yvo Ghoos; Paul Rutgeerts; G Vantrappen
Starch digestion in normal subjects and patients with pancreatic disease, using a 13CO2 breath test.
Gastroenterology 1989;96(2 Pt 1):503-9.
1988: Eric Van Cutsem; Paul Rutgeerts; Karel Geboes; F Van Gompel; G Vantrappen
Estrogen-progesterone treatment of Osler-Weber-Rendu disease.
Journal of clinical gastroenterology 1988;10(6):676-9.
1988: P Van Hootegem; K Van Besien; L Broeckaert; Paul Rutgeerts; Johan Fevery
Endoscopic sclerotherapy of esophageal varices. Long-term follow-up, recurrence, and survival.
Journal of clinical gastroenterology 1988;10(4):368-72.
1988: J Dequeker; B Grillet; L De Clerck; Paul Rutgeerts; Karel Geboes
Ileocolonoscopy and spondarthritis.
British journal of rheumatology 1988;27(3):246-7.
1988: K Geboes; Paul Rutgeerts; Freddy Penninckx; V Desmet; G Vantrappen
Changes in small intestinal epithelial expression of MHC class II antigen after terminal ileal resection for Crohn's disease.
International journal of colorectal disease 1988;3(2):102-8.
1988: Paul Rutgeerts; G Vantrappen; F D'Heygere; L Broeckaert
Transendoscopic Doppler ultrasound: usefulness for diagnosis and treatment of vascular malformations.
Endoscopy 1988;20(3):99-101.
1988: Yvo Ghoos; Paul Rutgeerts; G Vantrappen; Martin Hiele; P Schurmans
The effect of long-term fibre and starch intake by man on faecal bile acid excretion.
European journal of clinical investigation 1988;18(2):128-32.
1988: Paul Rutgeerts; G Vantrappen; L Broeckaert; M Muls; Karel Geboes; Georges Coremans; Jozef Janssens
Palliative Nd:YAG laser therapy for cancer of the esophagus and gastroesophageal junction: impact on the quality of remaining life.
Gastrointestinal endoscopy 1988;34(2):87-90.
1988: Karel Geboes; E De Jaeger; Paul Rutgeerts; G Vantrappen
Symptomatic gastrointestinal metastases from malignant melanoma. A clinical study.
Journal of clinical gastroenterology 1988;10(1):64-70.
1987: Paul Rutgeerts; Yvo Ghoos; G Vantrappen
Effects of partial ileocolectomy and Crohn's disease on biliary lipid secretion.
Digestive diseases and sciences 1987;32(11):1231-8.
1987: B Grillet; L de Clerck; J Dequeker; Paul Rutgeerts; Karel Geboes
Systematic ileocolonoscopy and bowel biopsy study in spondylarthropathy.
British journal of rheumatology 1987;26(5):338-40.
1987: Paul Rutgeerts; G Vantrappen; P Van Hootegem; L Broeckaert; Jozef Janssens; Georges Coremans; Karel Geboes
Neodymium-YAG laser photocoagulation versus multipolar electrocoagulation for the treatment of severely bleeding ulcers: a randomized comparison.
Gastrointestinal endoscopy 1987;33(3):199-202.
1985: Paul Rutgeerts; F Van Gompel; Karel Geboes; G Vantrappen; L Broeckaert; Georges Coremans
Long term results of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag laser photocoagulation.
Gut 1985;26(6):586-93.
1984: P Van Hootegem; Paul Rutgeerts; Johan Fevery; L Broeckaert; J de Groote; G Vantrappen
Sclerotherapy of oesophageal varices after variceal haemorrhage.
Endoscopy 1984;16(3):95-7.
1984: Paul Rutgeerts; G Vantrappen; L Broeckaert; Georges Coremans; Jozef Janssens; Karel Geboes
A new and effective technique of Yag laser photocoagulation for severe upper gastrointestinal bleeding.
Endoscopy 1984;16(3):115-7.
1982: Paul Rutgeerts; G Vantrappen; L Broeckaert; Jozef Janssens; Georges Coremans; Karel Geboes; P Schurmans
Controlled trial of YAG laser treatment of upper digestive hemorrhage.
Gastroenterology 1982;83(2):410-6.
1981: Paul Rutgeerts; H Hendrickx; Karel Geboes; E Ponette; L Broeckaert; G Vantrappen
Involvement of the upper digestive tract by systemic neurofibromatosis.
Gastrointestinal endoscopy 1981;27(1):22-5.